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Self-renewal and pluripotency are the two unique characteristics of embryonic 
stem cells (ESCs). At cellular level, self-renewal is defmed as the ability to generate 
daughter cells identical to their mother cells, while pluripotency refers to the ability to 
differentiate into cells of three germ layers. ESCs can self-renew indefinitely while 
maintaining their pluripotency. 
^ 1 
Ca is a universal second messenger which regulates enzyme activities, 
signaling pathways, transcription factors and even core elements of cell cycle 
machinery. Previous studies on other mammalian cells have shown that Ca^^ is 
n • • 2+ 
necessary for cell proliferation in culture. Ca entries can be via voltage-operated 
Ca2+ channels, store-operated Ca?+ channels (SOCCs) and/or receptor-operated Ca?+ 
channels. However, voltage-operated Ca�+ channel current cannot be detected in 
mouse ESCs (mESCs) by previous studies. In addition, Ca�+ was found to be released 
at an oscillatory pattem from the endoplasmic reticulum (ER) to the cytosol at Gi/S 
boundary in mESCs and this depletion of intracellular store of Ca^^ in ER can 
potentially activate SOCCs on the cell surface membrane. By the above evidence, we 
hypothesize that store-operated Ca�+ entry (SOCE) is an important Ca�+ source in 
mESCs which determines the self-renewal property of mESCs. 
The aims of the present investigation are 1) to test if the SOCCs are present in 
vii 
mESCs at molecular and functional levels; 2) to test if SOCE is related to the 
self-renewal of mESCs; 3) to identify if 17p-estradiol (E2) can maintain the 
self-renewal of mESCs and if this effect is mediated through SOCE; 4) to investigate 
whether Nuclear Factor of Activated T-cells O^FAT) is the downstream target of 
SOCE upon stimulation by E2. 
By routine PCR, SOCC candidates such as TRPC channels, STIM, and ORAI 
were found to be expressed at mRNA level in mESCs. By Ca:+ imaging using 
confocal microscopy, SOCE was found to exist in mESCs which could be blocked by 
putative SOCC blockers, La�+ and 2-APB. Addition of La�+ and 2-APB or reduction 
n 
of extracellular Ca^^ by EDTA reduced mESC proliferation in a 
concentration-dependent manner, suggesting that SOCE is important for ESC 
proliferation. Pluripotency marker Sox-2 was down-regulated by 2-APB, suggesting 
self-renewal property of mESCs relied on SOCE. 
Interestingly, proliferation could be enhanced by applying E2. This enhanced 
proliferation was associated with an increment of SOCE and down-regulation of 
ORAI3. Both stimulated proliferation and larger SOCE could be reversed by the 
application of 2-APB, suggesting that E2 mediates its effect on proliferation via 
enhancing SOCE. 
Furthermore, the downstream target of E2-enhanced SOCE was also investigated. 
viii 
The possible role of NFAT was studied. NFAT is activated by SOCE and can trigger 
long-term responses such as regulating transcription, proliferation and differentiation. 
Previous study from our group demonstrated the expression ofNFATc2, NFATc3, and 
NFATc4 in mESCs. By using westem blot and fluorescence microscopy, 
de-phosphorylation ofNFATc3 and nuclear translocation of GFP-NFATc4 by applying 
E2 could be observed, and these effects could be reversed by the application of 
2-APB, suggesting that NFATc3 and NFATc4 are downstream targets of E2-induced 
SOCE. In addition, application of cyclosporin A (CsA) (inhibitor of calcineurin which 
activates NFAT by de-phsophorylation) was found to reverse the proliferative effect 
H 
brought by E2. This suggested that NFAT is involved in E2-stimulated proliferation. 
This investigation is the first study to provide evidence that SOCE and NFAT affect 
















能保持mESCs的自我更新，及此效應是否涉及SOCE; 4 )調查活化T細胞核因 
子（NFAT)是否SOCE受到E2刺激後的下游目標。 
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CHAPTER ONE INTRODUCTION 
1.1 Embryonic Stem Cells (ESCs) 
1.1.1 Characteristics ofESCs 
Embryonic stem cells (ESCs) were first successfully isolated from mouse 
embryos in 1980s [1，2]. They are derived from the inner cell mass of early 
mammalian embryos called blastocysts. These cells can be distinguished from other 
cell types by three properties. 
First, ESCs are unspecialized. They do not have tissue-specific structure for 
carrying out specialized functions. For example, they cannot generate action 
n 
potential for signal transmission like a neuron, and it cannot communicate with its 
neighbor cells to contract for pumping blood like cardiac cells. However, these 
unspecialized cells can give rise to a wide variety of specialized cell types by a 
process called differentiation. 
Second, ESCs can undergo long-term self-renewal. Unlike other somatic cells 
like muscle cells or neurons, which can do not normally proliferate themselves, 
ESCs can replicate indefinitely in culture and continue to remain unspecialized, like 
*• 
their parent cells. -
Third, ESCs are said to be pluripotent. Pluripotency refers to an unspecialized 
stem cell that has a potential to differentiate into any three germs layers: endoderm, 
1 
mesoderm, and ectoderm. However, they are not able to develop into a fetus alone 
since they do not have the potential to develop into extraembryonic tissue like 
placenta. 
1.1.2 Therapeutic Potential of ESCs 
Nowadays, human immortalized cell lines are commonly used for drug 
screening assays because they are inexpensive, easy to handle and can generate 
results with high reproducibility. However, they may not be physiological equivalent 
to tissues inside human body as a result of immortalization [3]. Due to the 
n 
self-renewal and pluripotent properties of ESCs, ESCs have been proposed as 
candidate for pharmaceutical studies. Specific cell populations like neurons and 
hepatocytes can be generated from directed differentiation of ESCs in an unlimited 
supply and hence, they are good for screening of new tissue-target drugs to identify 
potential therapeutic medicine. 
Specific cell populations derived from ESCs are important cell sources for 
cell-based therapy. The methodology of this therapy involves the transplantation of 
•• 
derivatives from ESCs into bodies to replace or repair damaged tissue, and it had 
been proposed as future therapy in treating diseases such as Parkinson's disease [4， 
5], myocardial infarction [6，7]，and Type I diabetes [8，9]. 
2 
However, many technical hurdles have to be solved before cell-based therapy 
can enter clinical phase. One of the most important issues is the formation of 
teratoma (non-cancerous tumours) [10，11]. The formation of such tumor is due to 
the contamination of undifferentiated ESCs or unwanted ESCs derivatives during 
transplantion. Hence, it is urging to understand the mechanisms behind maintaining 
self-renewal and pluripotent characteristics of ESCs. 
In the present study, the self-renewal property of mouse ESCs (mESCs) was 
focused, and the mechanism of how 17p_estradiol (E2) maintains the self-renewal 
characteristic of mESCs was investigated. 
t» 
1.2 17P-estradiol (E2) 
1.2.1 Genomic Actions ofE2 
E2 is the most potent form of estrogen. It is mainly synthesized in the granulosa 
cells of the ovaries, as well as in the adrenal cortex. It exerts its effect globally, 
including on the reproductive organs, liver, brain, cardiovascular system, etc. [12， 
13]. In the following paragraphs, only the effect of E2 on regulating Ca^+ 
•• 
homeostasis at both genomic and non-genomic level will be discussed. 
In classical endocrinology, E2 is a steroid hormone that can diffuse through the 
plasma membrane and bind on the estrogen receptor (ER) located in the cytosol. The 
3 
binding initiates dimerization of the receptors; the dimer would subsequently migrate 
into the nucleus. This dimer acts as a transcription factor that binds on the estrogen 
responsive element (ERE) in the promoter region of target genes, and thus regulates 
its target gene expression. In addition, activated ER complex can interact with other 
transcription factors like Fos/Jun [14] or SP1 [15], and hence influence the 
expression of genes which do not possess ERE. This mode is known as the tethered 
pathway [12].(Figure 1). 
E2 signaling is mediated through two types of ERs, ERct, and ERp. Both of 
them are nuclear receptor of transcription factors. ERs have three functional domains, 
n 
which are divided into N-terminal region, central region and C-terminal region [12]. 
The less conserved region is the N-terminal one, which consists of activation 
function (AF)-1. The activity of AF-1 is in a ligand-independent manner, in contrast 
to the function of AF-2 (at C-terminal) which is induced by ligand binding [16, 17]. 
The central and the most conserved region, the DNA-binding domain, is involved in 
DNA recognition and binding through two zinc fingers [18，19]. Ligand binding 
occurs at C-terminal of ERs, where AF-2 locates. Two ERs have similar affinities 
•• 
towards E2 and have the same DNA response element [12]. 
Modulation of the expression level of Ca?+ channels by E2 has been extensively 
reported. In nervous system, E2 was reported to up-regulate the expression of T-type 
4 
2+ Ca channel subunit (Cav3.1) in hypothalamus and pituitary [20，21] and hence 
modulate the pacemaker activity, excitability or release of neurotransmitters [21]. 
Also, supplement of E2 could prevent an age-related increase in L-type Ca^^ current 
in neurons by down-regulating Cavl.2 [22]. 
In cardiovascular system, it was suggested a decrease in E2 could lead to an 
enhanced L-type Ca^^ channel expression functionally in cardiac ventricular cells 
[23]. This would lead to an abnormal cardiac excitability and an increased risk of 
arrhythmia. Apart from the heart, an increase in E2 could lead to a decrease of 
2+ • L-type Ca channel in coronary artery, and hence lower the incidence of coronary 
n 
events in pre-menopausal women [24]. 
Apart from the voltage-sensitive Ca�+ channels, expression level of 
Store-operated Ca�+ channels (SOCCs) could also be regulated by E2. TRPC4 was 
shown to be down-regulated in bovine aortic endothelial cells after 6 days treatment 
of l^iM E2 [25]. TRPV4, a relative of TRPC channel, was found to be up-regulated 
by incubation oflOnM E2 for 3 days in human breast cancer cell line [26]. 
«• 
1.2.2 Non-genomic Actions of E2 
Steroid hormones can regulate cellular functions by affecting the genomic 
events. This classical genomic pathway involves changes in gene expressions and 
5 
takes relatively long period of time (usually > 30 minutes). On the other hand, 
steroid hormones can also exert their effects in minutes or seconds, suggesting that 
the effect is transcriptional-independent. This rapid effect brought by steroid 
hormone is usually termed “non-genomic effect" [27] (Figure 1). 
Non-genomic actions of E2 have been extensively reviewed, and mostly 
involve the action from ERa, as well as membrane-bound ER. Binding of E2 to ERa 
can stimulate the following signaling cascades: (1) second messengers (Ca】+，cyclic 
adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), etc.)； 
(2) protein kinases (phosphoinositide 3-kinase (PI3K), mitogen-activated protein 
»s 
kinase (MAPK), protein kinase A (PKA), protein kinase C (PKC), etc.)； (3) ion 
channels (Ca?+ channels, K+ channels) [27-30]. 
E2 was found to regulate Ca^^ homeostasis in a non-genomic manner. E2 
(lpM-30^iM) reduced the L-type and T-type Ca?+ currents within seconds to minutes 
of administration in isolated cardiac myocytes [31，32]，A7r5 vascular smooth 
muscle cell line [33，34], human airway smooth muscle cells [35] and neurons [36， 
37]. In addition, E2 could initiate Ca，+ influx in maturing human oocyte by unknown 
•• 
pathway [38], and it could promote Ca�+ influx via L-type Ca�+ channels in rat 
hippocampal neurons [39] and in duodenal cells [40]. Apart from regulating the Ca�+ 
flux between cytosol and external solution, E2 (20nM) could trigger Ca�+ release 
6 
from intracellular store in astrocytes [41, 42]. In addition, E2 (lnM) could increase 
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Figure 1. Different molecular pathways triggered by E2. (A) The classic pathway 
includes direct binding of E2 to ER, dimerization of ER, translocation of the ER into 
the nucleus and finally binding of the dimer on ERE of the promoter region of 
E2-target genes. (B) The tethered pathway is similar to the classical pathway; 
however, activated ER interacts with other transcription factors (TF) and binds on 
non-ERE promoter region. (C) Mechanism of non-genomic pathway is not well 
understood. It probably involves a membrane-bound receptor which can be activated 
by E2, or classical ER in cytosol, and the activation of downstream targets including 
second messengers, kinases or ion channels and subsequently leading to the specific 
physiological responses. Transcriptional control is absent in the non-genomic 
pathway brought by E2. 
V 
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1.2.3 Physiological Roles of E2 on Early Mammalian Development 
The effect of E2 on early embryonic development is poorly understood. In the 
case of mouse embryonic development, matemal mRNA for ER exists in unfertilized 
state, but the mRNA level disappears up to around 3 days after fertilization. ER 
mRNA would reappear again in blastocyst stage (start from D3.5) due to the 
activation of embryonic genome. This might imply that ERs have functional roles in 
the development of preimplantation embryo [44]. Further study demonstrated the 
presence of ER protein in all cell types of the blastocyst (inner cell mass and 
trophoblast), and that the ER protein in the blastocyst is located in the nucleus. Also, 
ti 
the expression of ER protein in all cell types continues in the dormant and 
implanting blastocyst. These findings suggest that ER may have a general function 
during early embryonic development [45]. 
It is not surprising that proper embryonic development requires a tight 
regulation of estrogen level. Previous study showed that exposure to exogenous 
estrogen or estrogenic compound could lead to embryo lethality [46]. It is suggested 
that a sudden change in E2 concentration within individual rat rather than the 
•« 
absolute E2 concentration contributes to embryo lethality, since large variation in E2 
concentration between individual rats was observed [46, 47]. Interestingly, E2 
deprivation by aromatase inhibitor (anastrozole) did not show negative effect on the 
9 
developmental potential of mouse oocyte, including its fertilization and development 
into morulae, blastocysts and hatching blastocysts [48]. 
Either knockout of ERa or ERp is not lethal to mice embryo, but ER is 
necessary for later stage of embryonic development, including reproductive tracts, 
mammary gland, neuroendocrine system, etc. (For review see [49])，Also, E2 was 
found to regulate the osteogenic [50] and neuronal differentiation [51] of mESCs. 
Interestingly, E2 was also found to regulate the proliferation of mESCs [52] as 
discussed in the following paragraphs. 
M 
1.2.4 E2 and Cell Proliferation 
The stimulatory effect of E2 on cell proliferation had been reported in various 
cell types, such as keratinocytes [53], breast epithelial cells [54], uterine epithelial 
cells [55], and mESCs [52]. Detailed discussion about E2 on cell proliferation can be 
found elsewhere [56-60]. 
In the study of E2-induced proliferation in mESCs, E2 up-regulated the 
expression of protooncogenes (c-/o5, o-jun, and c-myc), cyclin D1 and cycKn E, as 
well as cyclin-dependent kinase (CDK) 2 and CDK4 via MAPK signaling, while 
p21''P' and p27^'^' (CDK-inhibitory proteins) were down-regulated [52]. 
Interestingly, promoter of cyclin D1 does not contain ERE [61]; this implies that E2 
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regulates cyclin D1 expression indirectly and hints that other transcription factors 
maybe involved in E2-induced mESCs proliferation. Therefore, the effects of E2 on 
ESC biology need to be explored further. 
1.3 Ca2+ Homeostasis 
1.3.1 Overview 
Intracellular Ca�+ is critical for cell physiology, therefore the Ca�+ level must be 
^ , ^ , 
tightly regulated by different sets of protein, including Ca channels, Ca pumps 
and exchangers [62] (Figure 2). 
•* 
In order to increase intracellular Ca，+ level, this can be achieved by either 
opening of Ca?+ channels on plasma membrane or opening of channels on the 
intracellular Ca�+ stores. Voltage-operated Ca�+ channels (VOCCs), which are 
activated by membrane depolarization, are important routes for Ca�+ influx in 
excitable cells. External stimuli such as glutamate or acetylcholine can trigger the 
opening of receptor-operated Ca�+ channels (ROCCs). SOCCs have drawn great 
attention in this decade; they are activated upon store-depletion. The detailed 
«• 
mechanism for activating SOCCs will be introduced later. 
Ryanodine receptors (RyRs) and inositol-1,4,5-trisphosphate receptor (IP3R) are 
the major Ca?+ channels responsible for Ca�+ release from the internal stores. RyRs 
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are important in skeletal muscle, smooth muscle and cardiac muscle cells, because 
1^ _^|_ 
they mediate a process called "Ca -induced Ca release" which is key to muscle 
contraction. High cytosolic Ca，+ level increases the activity ofRyRs [63]. In the case 
of IP3R, it is activated by low cytosolic Ca�+ level but inhibited at high Ca?+ level 
[64]. Also, IP3 acts as agonist 0fIP3R. Communication between RyR and IP3R often 
generates complex Ca�+ signal such as Ca�+ waves [65]. 
Once the signaling function is fulfilled, intracellular Ca�+ must be removed 
rapidly to avoid cytotoxic effects, this can be performed by various pumps and 
exchanger. Na+ZCa，+ exchanger (^CX) and the plasma membrane Ca^^-ATPase 
n 
(PMCA) can remove excess Ca^^ from cytosol to the extracellular region, while 
sarco-endoplasmic reticulum Ca^^-ATPase (SERCA) pumps Ca�+ back into 
intracellular stores [62]. 
Complex spatial and temporal Ca�+ signaling in cells controls wide range of cell 
functions including transcription, proliferation and differentiation [62]. Here, we will 
focus on the relationship between store-operated Ca�+ entry (SOCE) and the 
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Figure 2. Molecular candidates responsible for regulating Ca�+ homeostasis in cells. 
On the plasma membrane, the opening of Ca�+ channels, including VOCCs, ROCCs 
and SOCCs, allow Ca^+ influx from extemal solution to cytosol. While PMCA and 
^1 
NCX remove cytosolic Ca to extemal environment. RyR and IP3R are located on 
membrane of endoplasmic reticulum (ER) and are responsible for Ca?+ release from 
ER. SERCA on ER pumps cytosolic Ca^^ back to ER. 
*» 
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1.3.2 Ca2+ Signaling in mESCs 
Detailed study on Ca?+ homeostasis in mESCs was carried out by Yanagida et al. 
[66]. In this report, SOCE was found to be an important Ca!+ _ u x pathway, while 
1^ 
NCX and PMCA are components for Ca extrusion system. VOCCs, which are 
9+ 
important Ca channels in excitable cells, were found to be absent in mESCs [66， 
1^ 
67] . For channels responsible for Ca release from ER, only IP3R but not RyR was 
found in mESCs [67]. 
Ca2+ signaling including oscillation was found in mESCs [68]. The basis for 
initiating the signal was properly attributed to change in IP3R sensitivity or IP3 
«i 
production, and these oscillations were confined to the transition from the Gi phase 
to S phase of the cell cycle. It was believed that this signal plays role in mESC cell 
cycle progression. 
^1 
In addition to this Ca oscillation, extrinsic factors were also found to modulate 
mESC proliferation [69-79]. Among these factors, Ca^^ is involved in GABA [73], 
) 
angiotensin II [71], epinephrine [76], Sonic hedgehog [79] and epidermal growth 
factor [72] mediated proliferation of mESCs. 
«• 
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1.4 Store-operated Ca^ ^ Entry (SOCE) 
1.4.1 Overview 
Detailed description of SOCE has been reviewed extensively [80-82]. In most 
non-excitable cells, binding of certain extrinsic factors to G protein-coupled receptor 
and tyrosine kinase-coupled receptor will lead to activation of phospholipase C (PLC) 
and hydrolyse phosphatidyl inositol-bisphosphate (PIP2) into IP3 and diacylglycerol 
(DAG). IP3 acts as diffusible chemical messenger and activates IP3R on the surface 
membrane of intracellular Ca�+ stores, leading to the release calcium from the stores 
into cytosol and the generation of initial transient Ca�+ signal. Depletion of Ca?+ 
#1 
store is an important signal for SOCCs on plasma membrane and allows influx of 
Ca2+ from external solution. Sustained Ca^^ entry allows replenishment of 
intracellular stores, and also increases intracellular Ca�+ level for diverse cellular 
functions, including proliferation and differentiation. 
1.4.2 Store Depletion 
SOCE can be triggered by applying agonists which produce IP3, or using 
•« 
pharmacological tools to deplete Ca^^ stores. Certain growth factors such as 
platelet-derived growth factor (PDGF) [83], epidermal growth factor (EGF) [84], and 
interleukin-l(IL-l) [85] have been reported as agonists to initiate SOCE. In case of 
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mESCs, SOCE can be triggered by ATP or histamine [66]. In addition, SERCA 
blockers such as Tg or cyclopiazonic acid (CPA), and also IP3 (IP3R agonist), are 
commonly used in cell imaging experiments for monitoring Ca�+ changes; while 
EDTA and BAPTA are commonly added into intracellular solution in patch clamp 
experiments for passive depletion of intracellular Ca�+ stores [80]. 
1.4.3 Activation of SOCE 
Three fundamental mechanisms have been proposed for sending the store 
depleting signal to the plasma membrane for activating SOCCs [80]; they are (1) a 
*i 
\ 
diffusible message (Ca:+ influx factor (CIF) [86], protein kinase C (PKC) [87], 
calmodulin [88], etc.)； (2) conformation coupling mechanism (interaction between 
IP3R on ER surface and SOCs on plasma membrane) [89]; and (3) vesicle secretion 
(SOCs are located in the vesicle inside the cytosol, and can be inserted onto plasma 
membrane upon store-depletion) [90, 91]. However, the molecular mechanism 
remained controversial until the breakthrough came from RNAi screening. Single 
transmembrane ER proteins, STIM1 and STIM2 [92, 93], and also SOCCs 
•• 
candidates, 0RAI1, ORAI2 and ORAI3 [94-97], were identified to constitute SOCE. 
When the Ca?+ stores are filled, STIM1 exists as dimer. Store-depletion would 
lead to oligomerization “ and translocation of STIM1 to ER-plasma membrane 
16 
junction [98，99]. This proximity is enough for STIM1 to induce ORAI channels to 
form clusters in the adjacent membrane [100，101]. The C-terminal effector domain 
of STIM1 interacts with the distal coiled-coil domain of ORAI and hence opens 
ORAI for Ca2+ entry [102]. Gating ofTRPC channels by STIM1 was also discovered 
recently. STIM1 shows electrostatic interaction with TRPC channels and this is 
important for removing channel inhibition [77]. Details about interaction between 
STIMl and TRPC channels will be discussed later. 
1.5 Molecular Identities of SOCCs on Plasma Membrane 
n 
1.5.1 TRPC Channels 
After the successful cloning of first mammalian TRPC channels in 1995 [103, 
104], seven isoforms (TRPCl-7) have been described since then [105]. TRPC 
channels have been believed to be the SOCCs by different experiments, from 
over-expression to knockout studies [106-108]. Unfortunately, some studies had 
shown that certain TRPC channels could not be activated by store-depletion [109]. 
The contradictory results may be due to the highly complexity of channel assembly. 
*• 
TRPC channels are able to form heteromultimers, for example, the existence of 
TRPCl/4, TRPCl/5, or TRPCl/3/5 in brain [110, 111]. Furthermore, TRPC channels 
can interact with non-TRPC family such as K+ channel [112] and NCX [113]. 
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Recently, the discovery of STIM1 provides a molecular definition of SOCCs, the 
function of STIM is described above. According to Yuan et al., the abilities of 
TRPC1, TRPC4, and TRPC5 to directly interact with STIM1 were demonstrated 
[114]. TRPC3 and TRPC6 could not interact with STIMl，but their function can be 
indirectly mediated by STIMl due to heteromultimerization ofTRPC3 with TRPC1 
and TRPC6 with TRPC4. The remaining, TRPC7, was found to be unregulated by 
STIMl. Therefore, it was suggested that all TRPC channels (TRPC2 is a pseudogene 
in human), except TRPC7, behave as SOCCs [114]. 
*i 
1.5.2 ORAI Channels 
Mammalian has 3 isoforms of ORAI channels (ORAIl-3). The amplitude of 
SOCE was greatly enhanced by combination of STIMl and 0RAI1 expression, 
suggesting that 0RAI1 serves as SOCCs [115, 116]. ORAI2 behaved similarly as 
0RAI1, it can also enhance SOCE when co-expressed with STIMl, but it was less 
efficient than that of 0RAI1. Interestingly, Ca�+ currents from co-expression of 
ORAI3 and STIMl were below the detection limit [117]. 
«« 
1.5.3 Regulation of SOCCs at Different Levels 
Expression of TRPC channels is varied under various pathophysiological 
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conditions such as hypertrophy (angiontensin II，endothelin-1, phenylephrine) [118， 
119], hypoxia (hypoxia-inducible factor 1) [120，121], inflammation (tumor necrosis 
factor (TNF)-a) [122], and hypertension (aldosterone) [123]. It should be noted that 
the changes in mRNA level may not be reflected at protein level. For example, 
during pregnancy in the human myometrium, the mRNA levels for TRPC1, TRPC6, 
and TRPC7 were up-regulated, while protein levels o fTRPCl , TRPC3, TRPC4, and 
TRPC6 were up-regulated [124]. Detailed information about pathophysiological or 
hormonal regulation of TRPC expression is discussed in numerous reviews 
[125-131]. In addition to change in expression level, TRPC channels can undergo 
n 
different post-translational modifications including oxidation [132], phosphorylation 
[115, 133, 134], glycosylation [135], trafficking [136]. 
1.5.4 Functions ofSOCE 
Extensive studies have demonstrated the importance of STIM, ORAI and TRPC 
channels on cell proliferation [137-141] and differentiation [142-146] by using 
siRNA，over-expression, or specific blocking antibody. However, in-depth study 
«• 
about the downstream targets of SOCE is limited. One of these targets is a 
transcription factor called nuclear factor of activated T cells O^FAT). Another 
transcription factors such as NF -KB [147] and cAMP response element-binding 
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(CREB) protein [148, 149] are also regulated by SOCE. However, they are less 
studied than that ofNFAT. Therefore, we will only focus on NFAT here and details of 
NFAT will be introduced below. 
1.6 Nuclear Factor ofActivated T-cells GVFAT) 
1.6.1 Overview 
NFAT were first discovered in the immune system, and found to bind to the 
promoter of interleukin (IL)-2 in activated T-cells. Their expression are not restricted 
to immune cells, but was also found in neurons, cardiac cells, smooth muscle cells, 
n 
etc. The regulation and function of NFAT family proteins has been reviewed 
extensively [150-152] 
Based on the results from cloning experiments, 5 isoforms of NFAT, namely 
NFATcl, NFATc2, NFATc3, NFATc4, and NFAT5, were characterized [152]. Except 
NFAT5, all isoforms are regulated by Ca^Vcalmodulin-dependent phosphatase 
calcineurin (Cn) [152]. In the following part, we will focus on the first four NFAT 
proteins. 
«• 
All four isoforms of NFAT proteins have two major regions of sequence 
homology; they are the DNA-binding domain (DBD) and the NFAT homology 
region G^HR)[152]. • 
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1.6.2 Mechanisms of Action 
Activation of NFAT involves three different steps: de-phosphorylation, nuclear 
translocation, and increase DNA binding affinity [152]. SOCE is required in T-cells 
to maintain Cn and NFAT in an activated state. SOCE is activated by emptying of 
intracellular Ca^^ stores, leading to a prolonged Ca�+ influx. This increased 
intracellular Ca�+ leads to a sustained activation of Cn. Activated Cn interacts with 
the NHR domain in NFAT and leads to de-phosphorylation of that regulatory domain. 
As a result, the nuclear localization sequence O^LS) in NHR becomes accessible and 
exposes the residues involving DNA binding, leading to nuclear translocation and 
«j 
increment of DNA binding affinity [153]. Active form of NFAT in nucleus can be 
phosphorylated by GSK-3p, and this will result in the export of NFAT to the cytosol 
[154]. 
NFAT can work alone or cooperate with other partners to regulate gene 
transcription. When NFAT works alone, it can serve as a functional transcription 
factor can activate certain gene expression including TNF-a and IL-13 [155]. 
Interestingly, NFAT can be a repressor that binds to a site immediately downstream 
«« 
of the transcriptional start site and leads to down-regulation of CDK4 promoter 
activity [156]. Also, NFAT can interact with AP-1, GATA, and Cabinl-MEF2 to 
control gene expression [157]. 
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1.6.3 Functions 
NFAT signaling is found to be important in regulating cell fates including 
differentiation [158] and proliferation [159]. Studies from using knockout mice, 
biochemical assays and pharmacological tools, have demonstrated the involvement 
of NFAT in heart valve development p^FATcl) [160, 161], angiogenesis (NFATc2) 
[162], myogensis G^FATcl, NFATc2) [163], chondrogensis G^FATc2) [164], and 
differentiation of keratinocytes fNFATc3) [165] and adipocytes fNFATc2, NFATc4) 
[166]. Also, NFAT is found to regulate the proliferation of p-pancreatic cells 
CNFATcl) [167], prostate cancer cells (unknown) [159], smooth muscle cells 
(NFATcl) [168]，as well as lymphocytes (NFATc2) [169]. 
9+ 
The relationship between Ca，NFAT, and cell cycle progression has been 
^, 
discussed elsewhere [170]. Some experimental findings suggested that Ca 
stimulated certain gene expression associated with cell cycle progression (Gi/S phase 
transition) [170]. Also, NFAT was found to regulate the expression of numerous 
cyclins or CDKS, which are molecular players of cell cycle machinery [150, 156， 
171-173]. In addition, NFAT can induce the expression of Ca^^ channels and K+ 
«• 
channels,[174-176], and these channels can increase the availability of intracellular 
Ca2+，as well as regulating the membrane potential. These effects can ultimately 
control the cell cycle progression [170, 177-183]. Recent study from our group had 
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demonstrated that membrane hyperpolarization would favor the transition from Gi 
phase to S phase in mESCs [184]. Since hyperpolarization provides a greater driving 
force for Ca�+ influx, it is interesting to know if SOCE also involves in regulating 
proliferation of mESCs. 
1.7 Aims oftheStudy 
We hypothesized that in the absence of VOCCs, SOCE is an important Ca?+ 
source in mESCs which determines the self-renewal property of mESCs. The 
specific aims of this project were: ^ 
1) to test if the SOCCs are present in mESCs at molecular and functional levels; 
2) to test if SOCE is related to the self-renewal of mESCs; 
3) to identify if E2 can maintain the self-renewal of mESCs and if this effect is 
mediated through SOCE; 
4) to investigate whether NFAT is the downstream target of SOCE upon 
stimulation by E2. 
»• 
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CHAPTER TWO MATERIALS AND METHODS 
2.1 Maintenance of mESCs 
The mESC line D3 (ATCC, USA) was used. It was maintained on 
gelatin-coated culture dishes without feeder layer and propagated in Dulbecco's 
modified Eagle's medium (DMEM) (Invitrogen) supplemented with 15% fetal 
bovine serum (Hyclone), 2mM L-glutamine, O.lmM p-mercaptoethanol, O.lmM 
nonessential amino acids, and 1 ,OOOU/ml leukemia inhibitory factor (Chemicon) as 
we have previously described [67, 184, 185]. 
n 
2.2 Cell Proliferation Assay and Viability Test 
Cell proliferation was determined by simple cell counting technique. mESCs 
were treated with different concentrations of drugs or solvent (as control) for the 
entire period of the experiments. Cells were collected at 24，48 and 72 hours for cell 
counting. Numbers of viable and non-viable cells were determined by trypan blue 
exclusion assy. 
For 24 hours-cell proliferation assay, 1 x 10^ mESCs were seeded on 
«« 
gelatin-coated 12-well plate on Day -1. Culture medium was replaced by new 
medium supplemented with drugs on Day 0. Cells were collected at Day 1 for cell 
counting. Numbers of viable and non-viable cells were determined by trypan blue 
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exclusion assay. For proliferation assay to study the time- and 
concentration-dependent effects of 2-APB, 2 x 10^ mESCs were seeded on 
gelatin-coated 12-well plate on Day -1. Culture medium with drugs was changed 
everyday and cells were collected on Days 1，2 and 3 for trypan blue exclusion assay. 
2.3 RNA Preparation, Reverse Transcription (RT) and Quantitative 
Polymerase Chain Reaction (qPCR) 
Total RNA was extracted using Trizol reagent (Invitrogen) according to 
manufacturer's protocol. Extracted RNA was dissolved in DNase/RNase-free water 
$» 
(Gibco) and quantified by measuring absorbance at 260nm and 280nm (Thermo 
Scientific, NanoDrop ND-1000). Integrity of extracted RNA was confirmed by the 
presence of 28s and 18s rRNA by electrophoresis in 1% agarose gel. The resulting 
RNA was DNase I (Invitrogen)-treated and subjected to RT using SuperScript III 
reverse transcriptase (Invitrogen). Control reactions for RT-PCR were performed by 
using RNA sample that was not reverse transcribed into cDNA (no RT control), and 
replacing RT products with DNase/RNase-free water (no cDNA control). For PCR, 
•• 
gene-specific primers (Invitrogen) for the target and housekeeping genes were used 
(Table 1). For real-time qPCR, Power SYBR GREEN PCR Master Mix (Applied 
Biosystems) was used and qPCR reactions were performed with 7500 Fast Real-time 
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PCR system (Applied Biosystems). Each reaction was performed at least in triplicate 
under the following conditions: 50°C for 2 minutes; 95°C for 10 minutes; 40 cycles 
of 95°C for 15 seconds, 56°C or 60°C (depends on the genes; see Table 1) for 1 
minute. Melting curve analysis and electrophoresis of PCR products were performed 
to verify the authenticity of PCR products. For checking amplification efficiency by 
individual primer pairs, standard curve experiments were performed. The starting 
quantity of mESCs cDNA was 500ng and serial factor was 1:10. Five points were 
used in the standard curve. Primer pairs with PCR efficiency of 90-110 % were used 
for further experiments. 
•» 
Fold-changes in the relative mRNA expression of the target gene were 
determined using the 2'^^^^ method [186] in which the target gene was normalized to 
the housekeeping gene and the relative expression levels of different genes in 
experimental groups were normalized to that in control group. 
After PCR, the products were resolved on a 1% agarose (Sigma) gel with 
ethidium bromide (Sigma). The fluorescence images were captured under UV 




2.4 Total Protein Extraction 
Cells were harvested, washed with PBS once and lysed in ice-cold RIPA buffer 
containing PBS with 1% NP-40, 0.5% sodium deoxycholate, 1% SDS, 1% protease 
inhibitor cocktail [Leupeptin (l^g/mL), Aprotinin (5^g/mL), PMSF (lOO^g/mL), 
sodium orthovanadate (lOO^g/mL), EGTA (200^g/mL) and EDTA (200^ig/mL) and 
phosphatase inhibitor cocktail pSfaF (250mM), p_glycerolphosphate (500^g/mL) and 
HEPES (50mM, pH 7.3)]. The cell lysates were incubated on ice for 10 minutes, and 
centrifuged at 16000g for 20 minutes at 4°C. The supernatant was collected and the 
protein concentration was estimated by Bradford assay (Bio-Rad Laboratories). 
Aliquots of protein were stored at -80°C until performing electrophoresis. 
For the western blot in determining NFATc3 and NFATc4 phosphorylation 
status, cells were washed with PBS twice, and RIPA buffer was added directly to the 
wells of culture plate. Cells were dislodged by scraper and lysed by RIPA buffer. 
Proteins were then extracted according to the aforementioned processes. 
2.5 Measurement of Protein Concentration 
•• 
To determine the protein concentration, Bradford reagent was mixed with each 
sample in a flat bottom 96-well plate in duplicate. Bovine serum albumin (BSA) 
standards of various concentrations were also included. After incubation for 5 
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minutes at room temperature, the absorbance reading of each well was taken by a 
microplate reader (Model 3550, Bio-Rad) at wavelength 595nm. Protein 
concentration of each sample was then determined directly from the BSA standard 
curve. 
2.6 De-phosphorylation Assay 
Whole cell lysates were prepared from undifferentiated mESCs. Similar to total 
protein extraction, harvested cells were washed with PBS once and lysed in ice-cold 
IX NEBuffer3 (New England Biolabs), freshly supplemented with 0.5% NP-40 and 
n 
protease inhibitor cocktail [Leupeptin (l^g/mL), Aprotinin (5^g/mL), PMSF 
(lOO^ig/mL) and EGTA (200^g/mL)]. The cell lysates were incubated on ice for 10 
minutes and centrifuged at 16,000g for 20 minutes at 4°C. The supernatant was 
collected and the protein concentration was estimated by Bradford assay. Aliquots of 
protein lysate (30^ig) were treated with 30 units of alkaline phosphatase from calf 
intestine (CIP) (10,000 U/mL, New England Biolabs) at 37�C for 2 hours. Samples 
were then subjected to electrophoresis and analyzed by western blot. 
•• 
2.7 Western BIot 
Aliquots of total protein were mixed in 1:1 ratio with 2x sample loading buffer 
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containing 125mM Tris-HCl (pH 6.8), 4% SDS, 20% glycerol, 0.06% bromophenol 
blue and 10% p_mercaptoethanol. Depending on the molecular weight of target 
protein, samples were separated in 6-12.5% SDS polyacrylamide gel. Pre-stained 
Novex Sharp Standard marker (Invitrogen) was loaded in parallel as a standard 
molecular weight marker. The 4% stacking gel was electrophoresed at 50 volts for 45 
minutes while the separating gel was increased to 100 volts for 1.5-2 hours. After 
electrophoresis, the gel was electrophoretically transferred onto PVDF membranes 
(Millipore) with a Trans-blot SD wet transfer tetra-cell (Bio-Rad) at 100 volts for 
1-3 hours, duration of which depended on the size of target protein. Membranes 
were blocked for 1 hour at room temperature with 5% dried non-fat milk in 
Tris-buffered saline containing 0.1% Tween-20 (TBST). Incubation with primary 
antibodies was carried out at 4°C ovemight. For the determination of NFATc4 and 
ORAI3 antibody specificity, antigenic peptides were pre-incubated with 
corresponding antibodies (5:1 w/w) in 500^L of PBS at room temperature for 2 
hours before adding to 5% milk. After primary antibody probing, membranes were 
subjected to three successive washes in TBST, each for 15 minutes with gentle 
«• 
shaking. Membranes were next incubated with HRP-conjugated secondary antibody 
(DAKO) in the dilution of 1:5000 for 45 minutes at room temperature, followed by 
three successive 15-minute washes with TBST. Protein expression was detected by 
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enhanced chemiluminescent substrate (ECL: Pierce) and protein bands were 
visualized by film exposure. P-tubulin or H3 were used as internal controls. The 
density of the bands was quantified using AlphaEaseFC software (Alpha Innotech). 
2.8 Ca2+ Measurement by Confocal Microscopy 
2 X 10^ cells were seeded on gelatin-coated glass coverslip in 12-well on Day 
-1. Culture medium with drugs was changed on Day 0. As previously described [112], 
on the day of experiment (Day 1), cells were washed with normal physiological 
saline solution (NPSS), which contained KC1 5 mM, NaCl 140 mM, CaCb 1 mM, 
n 
MgCl2 1 mM, glucose 10 mM and Hepes 5 mM. Afterwards, cells were incubated in 
NPSS with 5 i^M Fluo-4 (Invitrogen) and 0.02% of pluronic acid F-127 (Sigma) at 
room temperature for 30 minutes in dark. After staining, cells were then washed with 
^ 1 
OPSS (NPSS minus Ca ) and recordings were started within 2 minutes. The 
fluorescence signal was recorded and analyzed by Fluoview FV1000 confocal laser 
scanning system (Olympus). Raw traces of Ca�+ change were shown as a ratio of 
fluorescence relative to the intensity at the beginning of recording (F/Fo), while fold 
*• 
changes of Ca�+ influx were defined as the fluorescence signal relative to the 
intensity before the application of extracellular Ca�+. Data analysis was performed 
with FV1000 software[li2]. 
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2.9 Ca2+ Measurement by Flow Cytometry 
Condition for seeding cells was same as the 24 hours-cell proliferation assay. 
mESCs were collected by trypsinization, washed with PBS by centrifugation at 1000 
rpm at 4 °C for 5 minutes. Cells pellets were resuspended in NPSS with 5^iM Fluo-4 
and 0.02% pluronic acid F-127 at room temperature for 30 minutes in dark. 
Afterwards, cells were centrifuged at 1000 rpm at 4°C for 5 minutes, and then 
resuspended in NPSS. The stained cells were then analyzed using flow cytometer 
FACSCanto (BD Biosciences) with the FACSDiva software (BD Biosciences) to 
measure calcium content as reflected by strength ofFITC signal (linear scale). 
2.10 siRNA Transfection 
4 sequences of siRNA targeting ORAI3 were purchased from Qiagen 
(Mm_BC061259_l, Mm_BC061259_2, Mm_BC061259_3, Mm_BC061259_4), 
while negative control siRNA was purchased from Ambion (AM4611). One day 
before transfection, 2 x 10^ mESCs were seeded on gelatin-coated 12-well plate dishes 
in lmL culture medium without antibiotics. For each transfection sample, 40pmol 
«• 
siRNA was diluted in 1 OO^L Opti-MEM reduced serum medium (Gibco) and mixed 
gently. At the same time, 2[iL lipofectamine 2000 (Invitrogen) was diluted in lOOfiL 
Opti-MEM reduced semm medium and incubated at room temperature for 5 minutes. 
Then, the diluted DNA and diluted lipofectamine 2000 were combined and incubated 
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at room temperature for 20 minutes. Afterwards, 200^L complexes were added to each 
well containing cells with fresh medium (without antibiotics). Cells were incubated at 
37°C with 5% CO2, medium was changed after 4-6 hours and cells were collected 
after 48-72 hours for testing knockdown efficiency. 
2.11 DNA Plasmid Transfection 
One day before transfection, mESCs at 8 xlO^ cells/well were seeded to 
gelatin-coated 12-well plate dishes in lmL culture medium without antibiotics so that 
cells would be �70°/o confluent at the time of transfection. For each transfection 
tt 
sample, 1.6|iig plasmid was diluted in 100^L Opti-MEM reduced serum medium and 
mixed gently. At the same time, 4)uL lipofectamine 2000 was diluted in 100^L 
Opti-MEM reduced serum medium and incubated at room temperature for 5 minutes. 
Then, the diluted DNA and diluted lipofectamine 2000 were combined and incubated 
at room temperature for 20 minutes. Afterwards, 200p,L complexes were added to each 
well containing cells with fresh medium (without antibiotics). Cells were incubated at 
37°C with 5% CO2, medium was changed after 4-6 hours and testing for transgene 
•“ 
expression was performed after 18-48 hours. . 
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2.12 Molecular and Fluorescence Imaging 
The effect of E2 on NFAT translocation was investigated by fluorescence imaging. 
The mESCs that were transfected with LV-GFP-NFATc4 plasmids were cultured with 
E2 and E2/2APB at 37�C in a humidified incubator with 5% CO2 supply for different 
periods of time. After a defined time, culture medium was aspirated and replaced by 
lmL NPSS. mESCs with GFP-NFATc4 protein expressed could be observed under the 
excitation at 485nm and emission at 530nm using a fluorescence microscope CNikon 
Eclipse Ti-U inverted microscope). Fluorescence images under a magnification of 
300X were captured by Spot camera (SPOT RT3 camera, Diagnostic Instruments). 
Fluorescence intensities of the captured images were recorded by MetaFluor software 
(MetaFluorV7.5.6.0 software). 
For data analysis, areas of nuclei and cytoplasm of various cells were randomly 
chosen from the captured images, fluorescence intensities of the corresponding areas 
were used to calculate the nuclear-to-cytoplasmic ratio of each cell. Around 20 cells 
were analysed each time. 
nuclear-to-cytoplasmic ratio = intensity of nucleus / intensity of cytoplasm 
«• 
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2.13 Statistical analysis 
Each experiment was repeated for at least three times. The results were 
expressed as mean 土 SEM. Statistical significance between two groups of means was 
determined using unpaired Student's t-test. p < 0.05 was considered to be statistically 
significant. 
2.14 Primers used in the Study 
Table 1: Primers List (Primers for probing genes encoding SOCC candidates and 
housekeeping gene in qPCR) ^ 
Primer Sequences Size GenBank Working Annealing 
(bp) accession number concentration temperature 
_ ) ( � C ) 
TRPC1 
5' Primer GCCATCTTTGTCACCAGGTT 182 NM_011643.2 0.1 60 
3'Primer GCTCGAGCAAACTTCCATTC 
TRPC2 
5'Primer AGAGAGTGCAGAGCCCAGAG 182 NM_011644.2 0.3 60 
3'Primer CACCACCGTCATCACTTTTG 
TRPC3 
5' Primer AATGGTTCCAGCAGTTGACC 164 NM_019510.2 0.3 56 
3'Primer TGAAGATGAGATCGCTGTGG ‘ 
TRPC4 




5'Primer GGAGGCACAACTTGAGAAGC 140 NM_009428.2 0.3 56 
3'Primer TAGCCCCTCATTTGTTTTGG 
TRPC6 
5' Primer CAGGCCCAGATTGATAAGGA 175 NM_013838.2 0.3 56 
3'Primer CCAGCTTTGGCTCTAACGAC 
TRPC7 
5'Primer GCTACGTGCTGTATGGGGTT 130 NM_012035.2 0.3 56 
3'Primer GCTCGAGCAAATTTCCACTC 
0RAI1 
5' Primer TCCCTGGTCAGCCATAAGAC 184 NM_175423.3 0.3 60 
3'Primer TCATGGAGAAGGGCATAAGG 
ORAI2 
5'Primer ATGTGGTCACCCATGGGCAGGA 110 NM_178751.3 0:1 60 
3’ Primer CCAGCCTTGAGCTTGCTGGCTT 
ORAI3 
5' Primer GAGCAGTTGTTTGCTCCTCC 154 NM_198424.3 0.3 60 
3'Primer AGTCACCAAGGGTGAAGTGG 
STIM1 
5'Primer GGAGTCTTAGGATCCCGGAG 245 NM_009287.4 0.3 56 
3'Primer CTTCCGGAGAGTTTGAGCAG 
STlM2 




5' Primer AGAGGGAAATCGTGCGTGAC 138 NM_007393.2 0.3 60 
3’ Primer CAATAGTGATGACCTGGCCGT 
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2.15 Drugs Used in the Study 
Table 2: Drugs Lists (Drugs used in the proliferation assays and Ca^+ imaging 
experiments) 
Drugs Description Solvent Source 
17p-estradiol Steroid hormone DMSO Sigma 
2-APB SOCE blocker DMSO Cayman 
Cyclosporin A Calcineurin DMSO Enzo Life Sciences 




EGTA Ca2+ chelator Water Sigma 
Ionomycin Ca:+ ionophore DMSO Tocris 
LaCl3 SOCE blocker Water Sigma 
Nifedipine VOCC blocker DMSO Sigma 
«4 
Thapsigargin SERCA blocker DMSO Tocris 
«• 
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2.16 Antibodies Used in the Study 
Table 3: Antibodies List (Antibodies against pluripotency markers, NFAT 
transcription factors, SOCC candidate, and housekeeping protein) 
Antibody Antibody dilution Expected size Company 
H3 1:10000 17kDa Abcam (Abl791) 
NFATc3 1:200 � 1 5 0 k D a Santa Cruz 
(observed) (sc-8321) 
NFATc4 1:600 � l l O k D a Genway 
(18-003-43424) 





Oct-4 1:200 43 kDa Santa Cruz 
(sc-5279) 
ORAI3 1:200 33 kDa Abcam (Ab59332) 
(observed 55 kDa) 
ORAI3 1:200 33 kDa Santa Cruz 
(observed 55 kDa) (sc-74784) 
Peptide 
(sc-74784p) 
Sox-2 1:2000 37kDa 
Abcam (Abl5830) 




3.1 Expression of SOCE in mESCs 
Expression of functional SOCE in mESCs was confirmed by confocal 
microscopy. mESCs were exposed to Ca^^-free solution in the beginning, a transient 
^ 1 
increase in cytosolic Ca could be detected shortly after the addition of Tg (2^iM), 
indicating Ca^^ release from intracellular stores occurred. After the Ca^+ level 
returned to basal level, the [Ca?+] in the external solution was switched from 0 to 
lmM; a sustained Ca!+ influx was detected in case of control, while this Ca�+ influx 
was significantly reduced when the cells were pretreated with puta|ive SOCE blocker, 
2-aminoethoxydiphenyl borate (2-APB) at lOO i^M (p<0,001 Vs control, n=l l ) 
(Figure 3A, B), suggesting that functional SOCE was present in mESCs. 
Unexpectedly, increase in intracellular [Ca�+] ([Ca^^]i) was detected when the 
external solution were switched from 0 to lmM Ca^^ without the prior addition ofTg, 
although this increase in [Ca^^]j was significantly lower than that of control (p<0.001 
Vs control, n=15) (Figure 3A, B). 
Previous studies demonstrated that Ca�+ entry after store-depletion was 
insensitive to VOCC blocker nifedipine but was blocked by SOCE blocker 
lanthanum (La]+) and 2-APB, confirming that the Ca�+ influx was a SOCE [187， 
188]. 
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2+ To further examine whether the Ca influx was a SOCE, another SOCE 
blocker La�+ and VOCC blocker nifedipine were used. Addition of nifedipine ( l ^M) 
after initiation of Ca�+ influx could not trigger obvious effect. However, application 
T l ^ 1 
of La (0.1，l^iM) could obviously reduce the amplitude of Ca influx (Figure 3C, 
n=3). 
Expression of possible SOCC candidates was determined at mRNA level. By 
RT-PCR, all isoforms of STIM (STIMl-2); ORAI (ORAIl-3); and certain isoforms 
of TRPC channels (TRPCl-4, 6-7) were found to be expressed in mESCs (n=6) 
(Figure lC). Worth to note, certain isoforms of TRPC channels^ ( T R P C 1 ^ ) were 
found to be expressed in all 6 different experiments, while TRPC6 (detected in 5 out 
of 6 experiments) and TRPC7 (detected in 4 out of 6 experiments) were detected 
occasionally. TRPC5 was not detected in all experiments (Figure 3D). 
m» 
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Figure 3A. Functional expression of store-operated Ca?+ entry (SOCE) in mESCs 
was studied by confocal microscopy. Representative Ca^^ imaging traces showing 
^1 
the presence of SOCE. In the absence of external Ca，addition of endoplasmic 
• 2 + • 2 + • reticulum (ER) Ca -ATPase inhibitor Tg at 2^M depleted the Ca store, causing a 
release of Ca!+ ^^ (he cytosol. When external Ca:+ was added, Ca?+ influx occurred. 
Pretreatment of lOO i^M 2-APB, a SOCE blocker, reduced this Ca^^ influx, indicating 
that this Ca2+ influx was SOCE. 
Figure 3B. Abar graph showing that 2-APB at 100^M significantly reduced the Ca?+ 
influx induced by store-depletion. Without the prior addition of Tg, Ca?+ influx was 
^1 
also detected but this increase in [Ca ]j was significantly lower than that of control. 
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Figure 3C. Representative Ca�+ imaging traces showing the effects of nifedipine and 
La3+ after initiation of Ca^+ influx. Reduction of Ca�+ influx was observed by adding 
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Figure 3D. RT-PCR showing the expression of different SOCCs candidate genes in 
mESCs. mRNA ofTRPCl , 2，3, 4, 6，7, ORAI 1-3, STIM 1-2, but not that ofTRPC5, 
were detected in mESCs. Primers of TRPC5 were shown to be functioning in 
positive control sample (data not shown). Similar results were obtained from 6 




3.2 SOCC Blockers Attenuated mESC Proliferation 
To study whether self-renewal of mESCs relies on Ca�+, certain groups of Ca^^ 
channel blockers with various concentrations were used. From the Figure 4A, SOCC 
blockers, La^^ (0.3^iM and 3^iM) and 2-APB (lO^iM and lOO^M), inhibited 
proliferation in a concentration-dependent manner. Similarly, proliferation was also 
^ 1 
significantly reduced by applying Ca -chelator EGTA at 2mM. In contrast, 
proliferation was found to be insensitive to nifedipine (l^M) that blocks VOCCs. 
Since 2-APB is a more specific SOCCs blocker when compared with La�+ [189], 
n 
2-APB was used to study the time- and concentration-dependent effects on the 
proliferation of mESCs. Proliferation and viability was determined by trypan blue 
assay as we have recently reported [190]. From Figure 4B, lO^iM of 2-APB was 
found to block proliferation on Day 3 (p<0.05 Vs control), while 100^M of 2-APB 
exerted its inhibitory effect on proliferation since Day 2 (p<0.05 and p<0.001 Vs 
control for Day 2 and Day 3, respectively). In contrast, 2-APB treatment did not 
affect the viability of mESCs during the entire course of experiment (Figure 4C). In 
•• 
order to examine whether reduction in proliferation is due to change in pluripotency, 
2-APB-treated cells were harvested on Day 3 and the expressions of pluripotency 
markers (Oct-4 and Sox-2) was studied by western blots. lOpM 2-APB treatment did 
not alter the expression levels of both Oct-4 and Sox-2 (Figure 4D, E). On the other 
43 
hand, 100^M 2-APB decreased the expression of Sox-2 (58.7±7.7% of control; 
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Figure 4A. Effects of La]+ and 2-APB, putative SOCE blockers, and external Ca^^, 
on the proliferation of mESCs. Both La]+ and 2-APB blocked mESC proliferation in 
a concentration-dependent manner. Chelation of external Ca^^ by EGTA also 
attenuated mESC proliferation. Nifedipine, a voltage-operated Ca!+ channel blocker, 
was used as a negative control. Values are mean 士 S.E.M. of 4 experiments. 
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Figure 4B. 2-APB blocked mESC proliferation in a concentration- and 
time-dependent manner. Values are mean 士 S.E.M. of 3 experiments, *p<0.05, 
***p<o ooi Vs solvent control group. 
Figure 4C. 2-APB treatment did not alter the viability of mESCs. Values are mean 士 
S.E.M. o f 3 experiments. ‘ 
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Figure 4D. Effects of 2-APB on expression of pluripotency markers, Oct-4 and 
Sox-2, in mESCs by westem blot. lO^M 2-APB did not change the expression of 
both pluripotency markers, while lOO i^M of 2-APB reduced expression of S"ox-2, but 
exerted no effect on expression of Oct-4. Values are mean 士 S.E�M. of 3 ^ 
experiments, *p<0.05 Vs solvent control group. 
Figure 4E. Representative western blots showing the relative expression of Oct-4 and 
Sox-2 of control and 2-APB-treated mESCs. P-tubulin was used as a loading control. 
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3.3 E2 Increased mESC Proliferation 
To determine if E2 has any effect on mESC proliferation and viability, trypan 
blue assay was conducted as described above. When mESCs were treated with lpM 
and lnM E2 for 24 hours, the proliferation of mESCs were found to increase to 
109.5±3.8o/o (p<0.05 Vs control, n=7) and 115.9±3.5% (p<0.01 Vs control, n=6) of 
the control level, respectively (Figure 5A). In contrast, E2 treatment did not affect 
the viability of mESCs in the experiments (Figure 5B). 
3.4 E2 Increased Intracellular Ca:+ ([Ca^^]j) Level in mESCs 
Flow cytometry was used to examine if incubation of E2 for 24 hours has any 
effect on regulating the basal [Ca^^]j in mESCs. A higher average fluorescence signal 
(linear scale) implies a higher [Ca^^]i in cells. In present study, lpM E2 caused a 
trend of increase in average Fluo-4 fluorescence signal to 115.2±6.95% (p=0.079, 
n=6) while lnM E2 significantly increased the fluorescence signal to 107.1士2.01% 
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Figure 5A. Effects of E2 on mESC proliferation. Application of physiological 
concentration of E2 at lpM and lnM increased mESC proliferation in a 
concentration-dependent manner. Values are mean 士 S.E.M. of 6-7 experiments. 
*p<0.05, **p<0.01 Vs solvent control group. “ 
Figure 5B. Effects of E2 on the viability of mESCs. E2 at lpM and lnM that were 
shown to increase mESC proliferation did not alter the viability of mESCs. Values 
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Figure 6. Effects of E2 treatment on [Ca ]j level as assessed by flow cytometry. E2 
lpM tended to increase the average Fluo-4 fluorescence intensity (p=0.079), while 
E2 lnM significantly increased the fluorescence signal when compare to control 
(n=6-7). *p<0.05 Vs solvent control group. ^ 
«• 
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3.5 E2 Increased the Amplitude of SOCE 
In this series of experiments, the effects of E2 on the functional expression of 
SOCE were investigated. When compared with control mESCs, mESCs treated with 
E2 had no significant difference in the amount of intracellular Ca�+ store as reflected 
by the similar amplitude of the transient Ca^^ increase caused by Tg (Figure 7A, B). 
2+ 
However, Ca influx was found to be enhanced by E2 in a concentration-dependent 
manner. lpM E2 caused a trend of increase in Ca�+ influx (8.54±0.79 Vs 7.10士0.43 
of control, p=0.09, n= l l ) while lnM E2 significantly increase the Ca^^ influx 
tt 
(9.24=t0.67; Vs 7.10i0.43 ofcontrol, p<0.05, n=13) (Figure 7A. B). 
3.6 Increase in mESC Proliferation and SOCE Caused by E2 Could be 
Reversed by SOCC Blocker 
Co-treatment of 0.3^M 2-APB with lnM E2 attenuated the enhancement of 
proliferation caused by lnM E2 (p<0.01 Vs lnM E2-treated group) while 0.3^iM 
2-APB did not affect mESC proliferation by itself (Figure 8A). Interestingly, 
«• 
co-treatment of 0.3^iM 2-APB with lnM E2 also reversed the increment of SOCE 
brought by lnM E2 (p<0.05 Vs lnM E2-treated group) while 0.3^M 2-APB alone 
did not affect SOCE (Figures 8B, C). Consistently, direct application of 0.3^iM 
2-APB also could not block SOCE (n=2) (see Figure 9). 
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Figure 7A. Effects of E2 treatment on intracellular Ca]+ store and Ca^^ influx 
induced by store-depletion as assessed by confocal microscopy. Bar graph showing 
the amount of Ca:+ released from ER and the amount of Ca�+ influx by SOCE upon 
lpM and lnM E2 treatment. E2 treatment did not alter the amount of C a � : released 
from ER while SOCE was found to be enhanced upon E2 treatment. Values are mean 
士 S.E.M. o f l l - 1 3 experiments, *p<0.05 Vs solvent control group. 
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Figure 8A. Effects of SOCC blocker on E2-induced increase in mESC proliferation. 
E2 at lnM increased the proliferation; this increase in proliferation was reversed by 
co-treatment with 0.3^M 2-APB. 0.3^iM 2-APB alone did not affect mESC 
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Figure 8B. Effects of E2 and 2-APB treatment on intracellular Ca�+ store and Ca^ + 
influx induced by store-depletion as assessed by confocal microscopy. Bar graph 
showing the amount of Ca?+ released from ER and the Ca�+ influx by SOCE upon 
treatment with different drugs. E2 treatment to mESCs did not change the Ca�+ 
release from ER but increased SOCE. This enhanced SOCE was reversed by 
co-treatment with 0.3^iM 2-APB. 0.3^M 2-APB alone did not affect the SOCE. 
Values are mean 士 S.E.M. oflO-15 experiments, *p<0.05 Vs solvent control group. 
Figure 8C. Representative Ca:+ imaging traces showing the Ca�+ release from ER 
upon depletion by Tg and the subsequent Ca�+ influx induced by store depletion 
upon addition of external Ca�+ of experiments in B). 54 
(Figure 17). 
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Figure 9. Effect of 2-APB on SOCE. Ca?+ influx was not inhibited by both 0.1 and 
0.3^M 2-APB, but it was obviously blocked by l^iM 2-APB (n=2). 
«• 
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3.7 Relative Expression of SOCC Candidates at mRNA Level Under the 
Treatment of E2 
The change in relative expression of SOCC candidates was studied by using 
real-time PCR in order to dissect the mechanism behind E2-induced SOCE. ORAI3 
was shown to be down-regulated by E2 to 76.7±7.79% (p<0.05 vs control, n=6) of 
the control level, while expression levels of other SOCE candidates were not altered 
(Figure 10). 
3.8 E2 Down-regulated the Expression of ORAI3 . 
To determine whether E2 treatment would also affect ORAI3 expression at 
protein level, western blotting was performed. ORAI3 antibodies from 2 different 
companies were used. Antibody from Abcam (Lot: 689582) usually gave a single 
band at -55kDa (Figure 11), which is much larger than the predicted size (31kDa) 
[191]. In order to confirm whether that band represents ORAI3, another ORAI3 
antibody from Santa Cruz (Lot: H1809) was used. Multiple bands were observed 
when Santa Cruz antibody was used (Figure 11); interestingly, the band at � 5 5 k D a 
disappeared when antibody was neutralized by excess antigenic peptide (Figure 11)， 
suggesting that this band at 55kDa is the specific band representing ORAI3. Worth to 
note, no band could be detected at the predicted size when both antibodies were used 
56 
(n=2) (Figure 11). 
Consistent with the results from real-time PCR, down-regulation of ORAI3 was 
detected by westem blot when mESC were treated with E2 to 68.5±12.11% (p<0.05 






_ i i l I j _ _ _ _ _ _ 
�"7、〜八、一 
Figure 10. Expression of various SOCC candidates in E2-treated and control mESCs 
was studied by real-time PCR. Expressions of genes in E2-treated mESCs were 
normalized to that of control mESCs. Dotted line represents the normalized 
expression level of various genes in control mESCs. Expression of ORAI3 was 
found to be down-regulated while others remained unchanged upon E2 treatment. 
Values are mean 士 S.E.M. of 6 experiments. * p<0.05 for values of E2-treated 
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Figure 11. Representative westem blots using ORAI3 antibody purchased from 
Abcam and Santa Cruz are shown in lane 1 and lane 2-3, respectively. 
Pre-adsorption experiment was done for Santa Cruz antibody and the westem blot is 
shown in lane 3 (n=3). Band at -55kDa represents the ORAI3 protein as indicated by 
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Figure 12A. Westem blot analysis showing the relative expression of ORAI3 in 
control and E2-treated mESCs. E2 treatment decreased the expression of ORAI3 at 
protein level. Values are mean 士 S.E.M. of 6 experiments. * p<0.05 for values of 
E2-treated mESCs Vs that ofcontrol mESCs. 
Figure 12B. Representative westem blots showing the expression of ORAI3 proteins 
in control and E2-treated mESCs. H3 was used as a loading control. 
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3.9 Knockdown of ORAI3 in mESCs 
In order to test whether down-regulation of ORAI3 would lead an increase in 
SOCE, ORAI3 knockdown experiments were carried out. 4 siRNAs for ORAI3 
knockdown were purchased from Qiagen and they were transfected into mESCs 
separately for determination of knockdown efficiency by comparing the ORAI3 
protein amount between ORAI3 siRNA-transfected group and negative control 
group. From Figure 13A, the "siRNA 3" were found to be the most effective one on 
Day 3 (n=2) and therefore it was chosen for further experiment. 
Since the transfected cells had to be subjected to confocal microscopy for 
measuring the magnitude of SOCE, they had to be seeded on glass coverslip. 
However, they tended to form a ball cluster and this brought technical problems for 
Ca2+ imaging. In order to solve this problem, cells were seeded at most 2 days before 
confocal experiment. Therefore, cells must be split once during the 3 days of 
transfection experiment. 
It was planned to split cells after 48 hours of transfection and to perform Ca?+ 
imaging 24 hours later. Western blots were carried out in order to examin? whether 
this arrangement would change the knockdown efficiency of "siRNA 3". From 
Figure 13B, it was found that ORAI3 was no longer knocked-down (n=3). In these 
experiments, another Cy3-labeled siRNA was transfected into mESCs in order to 
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Figure 13A 
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Figure 13A. Representative western blots showing the expression of ORAI3 protein 
upon treatment with 4 different ORAI3 siRNAs and negative control siRNAs. 
mESCs were harvested at 48^ ^ and 11}^  hour after transfection for westem blots. 
"siRNA 3" was found to be the most effective one for knocking-down ORAI3 (n=3). 
Figure 13B. Representative westem blots showing the knockdown effect by 
"siRNA3" in mESCs which were split once at 48^ ^ hour and seeded on glass 
coverslip for growing additional 24 hours (n=3). 
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confirm the successfulness of transfection each time. The fluorescence signal by Cy3 
could be observed until 48 hours after transfection (data not shown), indicating that 
the transfection was successful, and the failure of ORAI3 knockdown was not due to 
the problem of transfection. 
3.10 Identification of NFATc3 Specific Bands 
Whole cell lysates from mESCs were prepared and westem blots were 
conducted with antibody recognizing NFATc3 (Santa Cruz sc-8321). However, 
multiple bands (ranged from �130kDa to 260kDa) could be observed, presumably 
due to the presence of both phosphorylated and non-phosphorylated forms as 
previously reported [152] (Figure 14). Therefore, treatment with calf intestinal 
alkaline phosphatase (CIP), which can remove phosphate groups from proteins, were 
carried out in order to identify the specific band(s) for NFATc3, especially specific 
bands for phosphorylated forms of NFATc3 (p-NFATc3). We hypothesized that CIP 
could remove the phosphate groups on NFATc3 and hence bands for p-NFATc3 
would disappear. From Figure 14，cell lyates from mESCs were prepared by two 
different buffers, the commonly-used RIPA buffer (lane 1)，and the NEB buffer 3 
(buffer for CIP treatment, lane 2). The band patterns between lane 1 and lane 2 were 
similar. After CIP treatment (lane 3)，the continuous bands at -160kDa disappeared 
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Figure 14 
Lane 1 2 3 
Undiff mESCs Undiff mESCs 
(RIPAbuffer) _ B buffer3) 
0 min 120 min of CIP treatment 
260kDa —— S ' & | i i • ‘ 
-a_:pfeh"=_-
1— _ 驅 歡 ‘ 
80kDa iii- 各 “ ^ f t . t ~ ‘ N ^ ^ , , … 
^ ^ ^ ^ ^ ^ y | H g j | | p ^ ^ � D e p h o s p h o r y l a t e d -
WP^m N F -
_—_• ^ :jf 
觀 r ' P i . . . & 3 * . A 
Figure 14. Representative westem blot showing the effect of CIP treatment on the 
phosphorylation status of NFATc3. No obvious pattern difference is observed 
between sample prepared from RIPA buffer (lane 1) and NEB buffer 3 (lane 2). After 
CIP treatment for 120 minutes (lane 3), continuous bands at -160kDa (indicated by 
red arrow) disappeared, while the band at the bottom of the continuous bands 
(indicated by blue arrow) remained, suggesting that this band probably was 
de-phosphorylated-NFATc3 (n=5). 
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while the band located at the bottom of the continuous bands remained. This result 
suggested that the continuous bands represented p-NFATc3 and the band at the 
bottom of the continuous bands was de-phosphorylated-NFATc3. 
Phosphorylation status of NFATc3 is regulated by [Ca^^]j level, as well as the 
direct control by Cn [152]. In order to further confirm the identity of bands on 
NFATc3 western blots, whole cell lysates from ionomycin- and cyclosporin A 
(CsA)-treated mESCs were prepared, which served as positive controls. We 
hypothesized that ionomycin could increase intracellular Ca:+ globally and 
de-phosphorylate NFATc3, and would ultimately be reflected as the downward 
shifting of the NFATc3 bands. We also hypothesized that NFATc3 would be 
phosphorylated under CsA (Cn inhibitor) treatment, and finally lead to an upward 
shifting of the NFATc3 bands. l^iM ionomycin treatment for 5-30 minutes caused an 
obvious downward shift of the continuous bands when compare to DMSO control. 
This effect disappeared when mESCs were exposed to a longer time of incubation 
with ionomycin (45-60 minutes) (Figure 15A). The reverse was seen for the case of 
CsA-treated mESCs: an obvious upward shift of continuous bands could be,observed 
when compare to DMSO control (Figure 15B). To conclude, by using CIP, 
ionomycin, and CsA treatment, specific bands for NFATc3 in mESCs were identified 
and they were located at -160kDa. 
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(Figure 17). 
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Figure 15A. Representative western blot showing the effect of ionomycin (l^iM) on 
the phosphorylation status of NFATc3, majority of continuous bands is indicated by 
red arrows. Cells were replaced by fresh culture medium 1 hour before the beginning 
of experiment. Ionomycin (l^iM) and DMSO were directly added to medium for 
incubation (n=3). 
Figure 15B. Representative western blot showing the effect of CsA (lO^M) on the 
phosphorylation status of NFATc3. Cells were replaced by fresh culture medium 1 
hour before the beginning of experiment. CsA ( 1 0 _ and DMSO were directly 
added to medium for incubation (n=2). 
•« 
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3.11 E2 Increased the Phosphorylation of NFATc3 
As SOCE in mESCs was enhanced after incubation of E2 (Figure 5), and NFAT 
is known to be a downstream target of SOCE [152], we hypothesized that more 
de-phosphorylated form of NFATc3 would be observed upon E2 treatment. mESCs 
were incubated with E2 up to 24 hours, and they were collected in every 4 hours 
(n=3) (Figure 16A). At 20^ ^ hour, a slight yet repeatable (n=3) downward 
electromobility shift of NFATc3 bands was observed in E2-treated group when 
compared to control (Figure 16B). 2 out o f 3 experiments showed that 0.3^iM 2-APB 
could reverse the effect o f E 2 on NFATc3 de-phosphorylation (Eigure 16B). On the 
other hand, phosphorylation ofNFATc3 was clearly shown in the 3^iM CsA-treated 
sample in all time points, while this effect could not be reversed by E2 (Figure 16A). 
3.12 Effects of 2-APB on NFATc3 Phosphorylation Status 
As shown in the above section, lO^iM 2-APB could reduce mESC proliferation 
(Figure 4B), indicating that SOCE is related to mESC proliferation. We hypothesized 
that 2-APB treatment would lead to phosphorylation of NFATc3 as om of the 
mechanisms to attenuate proliferation. mESCs were treated with 2-APB (l-lO^iM) 
for 3 days and collected every day. However, no difference in terms of 
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Figure 16A. Representative western blots showing the effects of E2, 2-APB, and 
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Figure 16B. Enlarged version of the western blot at "20^^ hour" in Figure 16A. The 
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Figure 17. Representative western blots showing the effects of 2-APB on NFATC3 
phosphorylation status in mESCs in three days treatment (n=3). 
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3.13 Identification of NFATc4 Specific Bands 
Two antibodies recognizing NFATc4 were used in the present study. Antibody 
purchased from Genway gave 2 bands at - l lOkDa (Figure 18A). Another one 
purchased from Santa Cruz gave single band at llOkDa, and this band disappeared 
when the antibody was neutralized by excess antigenic peptide (Figure 18B). 
Unexpectedly, the bottom band at llOkDa probed by NFATc4 antibody (Genway) 
vanished after treatment of CIP (Figure 19A, n=5), while a thick band at -60kDa 
was observed in CIP-treated group, which was later found to be CIP itself (predicted 
molecular weight: 69kDa, Figure 19B). Similarly, disappearance of the single band 
probed by NFATc4 antibody from Santa Cruz was also observed upon CIP treatment 
(Figure 19C, n=5). Surprisingly, no electromobility shift of this band could be 
observed for ionomycin- (Figure 20A, n=3) or CsA-treated mESCs (Figure 20B, 
n=2-3) when both antibodies were used. Since both positive control experiments 
could not allow us to identify the specific band of NFATc4, over-expression of 
GFP-NFATc4 in mESCs were done in order to study the relationship between E2, 
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Figure 18A. Representative westem blot showing the expression of NFATc4 in 
mESCs by using specific NFATc4 antibody purchased from Genway (n=4). Two 
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Figure 18B. Representative western blot showing the expression of NFATc4 in 
mESCs by using specific NFATc4 antibody purchased from Santa Cruz (lane 1). The 
band at llOkDa disappeared in pre-adsorption experiments, which were done by 
adding excess antigenic peptide to primary antibody, and the result was shown in 
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Figure 19A. Representative westem blot showing the effect of CIP treatment on 
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Figure 19B. Representative westem blot showing the CIP enzyme itself can be 
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Figure 19C. Representative western blot showing the effect of CIP treatment on 
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Figure 20A. Representative westem blots showing the effect of ionomycin treatment 
for various times on the NFATc4 phosphorylation status by using antibodies 
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Figure 20B. Representative westem blots showing the effect of CsA (lO^iM) 
treatment for 4 hours on the NFATc4 phosphorylation status by using antibodies 
purchased from Genway (Left) and Santa Cruz (Right) (n=2-3). 
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3.14 E2 Increased the Translocation of GFP-NFATc4 From the Cytoplasm to 
the Nucleus and This Effect Could be Reversed by 2-APB 
LV-EF1 a-GFP-NFATc4 plasmid was constructed in our lab previously. This 
plasmid was transfected into mESCs and the appearance of green fluorescence signal 
under fluorescence microscope indicated the successful expression of GFP-NFATc4 
fusion protein (Figure 21A). The nuclear to cytoplasmic flsf/C) fluorescence signals 
were monitored every 4 hours upon lnM E2 treatment. At the beginning of 
experiment, fluorescence signal mainly localized in cytoplasm. The N/C ratio of 
control group remained relatively steady throughout the whole course of experiment. 
For the E2-treated group, the N/C ratio began to increase at 8�卜 hour and reached the 
peak at 12出 hour, indicating that translocation of GFP-NFATc4 from cytoplasm to 
nucleus occurred. This N/C ratio of E2-treated group remained higher than that of 
control until 20出 hour, and it started to decline. The effect of E2 on triggering 
GFP-NFATc4 nuclear translocation was reversed by co-treatment of lnM E2 and 
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Figure 21A. E2 triggered the nuclear translocation of GFP-NFATc4. Representative 
fluorescence figures of mESCs transfected with GFP-NFATc4. A) At time 0，the 
majority of GFP-NFATc4 was localized within the cytoplasm. B) 12 hour after 
incubation of DMSO, no obvious change in the amount of GFP-NFATc4 within the 
nucleus. C) 12 hours after incubation of E2 lnM, more GFP-NFATc4 was observed 
within the nucleus. D) 0.3^iM 2-APB blocked the nuclear translocation of 
GFP-NFATc4 induced by E2, 
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Figure 21B. Effect o f E 2 and 2-APB on the nuclear translocation of GFP-NFATc4 in 
mESCs. Quantification of the fluorescence images demonstrated that lnM E2 
significantly increased the N/C ratio ofGFP-NFATc4 at different time-points; 0.3^M 
2-APB reversed the effect of E2 on inducing GFP-NFATc4 nuclear translocation. 
Values are mean 士 S.E.M. of 3 experiments, *p<0.05 Vs control group, #p<0.05 Vs 
E2 + 2-APB group, ^p<0.001 Vs E2 + 2-APB group. 81 
3.15 CsA Reversed E2-induced Increase in Proliferation 
In order to examine whether NFAT translocation is involved in E2-induced 
proliferation, the effect of CsA, a Cn inhibitor, on mESC proliferation was tested. 
CsA at 3^iM, which did not affect mESCs proliferation by itself, was found to totally 
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Figure 22. Effects of CsA on E2-induced increase in mESC proliferation. E2 at lnM 
increased the proliferation; this increase in proliferation was reversed by 
co-treatment with 3^iM CsA. 3|_iM CsA alone did not affect mESC proliferation. 
Values are mean 士 S.E.M. of 4 experiments, *p<0.05 Vs solvent control group. 
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CHPATER FOUR DISCUSSION 
4.1 Expression of SOCE in mESCs 
Expression of SOCCs in mESCs was studied in the present investigation. Ca!+ is 
a key second messenger for cell signaling. Due to absence of VOCCs [66，67], Ca�+ 
influx via SOCCs is believed to be an important route for mESCs to obtain 
extracellular Ca?+. Previous study showed the existence of functional SOCE by 
calcium imaging technique [66]. 
Various previous studies suggested that candidates of SOCCs include TRPC 
family (TRPCl-7), STIM (STIMl-2), and ORAI (ORAIl-3) [97，102, 105]. 
Previous study by Yanagida et al. investigating the expression of TRPC family in 
mESCs by RT-PCR showed that only TRPC1 and TRPC2 were detected among the 
seven TRPC isoforms [66]. However, whether other SOCC candidates express in 
mESCs remains unknown. In our present study, we have investigated whether there 
is functional expression of SOCE in mESCs, and whether SOCC candidates, 
including TRPC, STIM and ORAI, are expressed, at least, at the mRNA level. 
Functional expression of SOCE was demonstrated by using confocal microscopy. By 
using real-time-PCR，we have demonstrated the expression of STIMl—2, ORAIl-3, 
as well as all TRPC members excluding TRPC5. Although more TRPC members 
were found to be expressed in our study when compared with that of the previous 
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study [66], TRPC1 and TRPC2 are the most abundant members (Cj value: -25-30), 
while other TRPC members are only expressed at a very low level (Ci value: >30). 
In these two independent studies, we believed that TRPC1 and TRPC2 are the major 
SOCCs in mESCs based on their relatively high expression levels when compare to 
other TRPC members. However, there were slightly difference in terms of culture 
conditions (concentration of fetal bovine serum, feeder layer system) between 
Yanagida et al and our group, this may explain why the other TRPC candidates can 
be detected even they were expressed at a low level. 
t* 
4.2 Proliferation of mESCs Depends on SOCE 
As SOCE was expressed at both molecular and functional levels, we were 
interested in the relationship between SOCE and the self-renewal properties of 
mESCs. Application of SOCC blockers (La]+ and 2-APB) was found to decrease the 
proliferation of mESCs in a concentration-dependent manner. The possible causes of 
this attenuation of mESC proliferation, including the change in viability and loss of 
pluripotency and thereby differentiation, were investigated. 
«• 
Our results showed that SOCC blockade did not alter mESC viability. 
Interestingly, the expression of pluripotency markers, Sox-2, was down-regulated by 
100|aM 2-APB (but not by lO^iM 2-APB) after 3 days treatment, while the 
expression of Oct-4 was unaffected by 2-APB at any concentration tested. Sox-2 is 
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known to be down-regulated earlier than Oct-4 during mESCs differentiation [192， 
193], meaning that loss of Sox-2 is an indicator of early differentiation. This 
indicates that mESCs treated with 100^M 2-APB had tendency to differentiate. 
Interestingly, expression level of Sox-2 was down-regulated in mouse embryonic 
heart by CsA (80mg/kg/day) [194]. This suggested that Cn/NFAT signaling 
(downstream pathway of SOCE) may contribute to the regulation of Sox-2 
expression. The relationship between NFAT and self-renewal will be discussed later. 
^ 1 
Spontaneous Ca oscillations were previously recorded in mESCs [68]. These 
Ca2+ signals appeared preferably at G! phase but not other phases, hinting that these 
Ca2+ signal may be essential for cell cycle progression from G! phase to S phase [68]. 
Since the oscillations can be blocked by inhibiting Ca�+ release from ER, implying 
that store-emptying events has occurred and these might in tum stimulate SOCE on 
plasma membrane. The results from this previous study therefore hint that the 
amplitude of SOCE in different cell cycle phases may vary. Separately, our group 
recently showed that membrane hyperpolarization is necessary for mESCs at Gi 
phase to enter S phase [184]. As hyperpolarization contributes a greater drjving force 
for SOCE, SOCE may be important for the Gi/S transition. The role of SOCE in 
particular cell cycle phase of mESCs remains to be explored in future. 
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4.3 E2 Acts an Extrinsic Factor for Stimulating Proliferation of mESCs Via 
SOCE 
In classical view on the action of E2, E2 diffuses through plasma membrane and 
forms complex with ER to serve as a transcriptional factor. In our study, E2 (lpM 
and lnM) was found to be an extrinsic factor which can stimulate the proliferation of 
mESCs, consistent with what had been previously reported [52]. Han et al. 
discovered that the protein expressions of certain protooneogenes (c-Fos, c-myc, and 
c-Jun) and cell cycle regulatory proteins (cyclin D1, cyclin E, p21 and p27) were 
up-regulated by applying E2 in mESCs [52]. In our project, we further explore the 
mechanisms of E2 on maintaining proliferation of mESCs apart from what had been 
studied from Han et al. As SOCE was shown to be important in regulating the 
self-renewal, we tested whether the underlying mechanism of E2-induced 
proliferation involved SOCE or not. 
In our present study, we showed that 2-APB at 1 i^M did not affect proliferation 
of mESCs. Therefore, a lower concentration of 2-APB (0.3^M) was used to ensure 
that 2-APB alone at this concentration would not affect proliferation. Interestingly, 
co-treatment o fE2 (lnM) and 2-APB (0.3^iM) could reverse the stimulatory effect of 
E2 (lnM) on proliferation. This data strongly suggested that 2-APB-sensitve 
mechanism was involved in the action of E2. By using confocal microscopy to 
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measure the magnitude of SOCE, SOCE was found to be enhanced by E2 (lnM), but 
the effect was abolished by co-treatment with 2-APB (0.3^iM), given that 2-APB 
(0.3^iM) alone did not affect the SOCE. By both proliferation and Ca�+ imaging data, 
we were convinced to believe the involvement of SOCE in E2-induced mESCs 
proliferation. Here, we are first to demonstrate the existence of hormonal modulation 
ofSOCE in mESCs. 
In these decades, non-genomic pathway of E2 was discovered, suggesting that 
E2 can regulate the cell physiology independent of the classical ER. In the report 
from Han et al., E2 was found to regulate proliferation of mESCs in a non-genomic 
pathway [52]. We were interested to know whether E2 can alter Ca�+ homeostasis, 
especially the SOCE, in mESCs via non-genomic pathway. Non-genomic action of 
E2 includes regulating activities of MAPK, PKA, PKC, as well as intracellular Ca^^ 
level [195]. E2 had been reported to trigger Ca?+ release or Ca:+ influx via 
non-genomic pathway in different cell types including canine kidney cells [196], 
human endometrium RL95-2 cells [197], and rat enterocytes [198], these effects 
were initiated after seconds to minutes of adding E2. However, we found that E2 
could not elicit any Ca�+ influx in - 1 0 minutes (concentrations from lpM to l^iM 
were tested; data not shown). This gave us some hints that E2 might not be able to 
trigger SOCE acutely in mESCs via the non-genomic pathway. Therefore, genomic 
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pathway was probably involved in the increment of SOCE that brought by E2 after 
24 hours. In order to further confirm whether the action brought by E2 in the present 
study was mediated through genomic or non-genomic pathway, experiments could 
be repeated by using E2-BSA instead of E2, so as to preventing activation of ER 
inside in the cells. 
4.4 Proposed Mechanism to Show an Increment of SOCE Can Be Due to a 
Down-regulation of ORAI3 
ORAI is one of the molecular players for SOCE. It includes 3 isoforms: 
ORAIl-3. ORAI channels are composed of 4 subunits, which can be homomer or 
heteromer [191]. Some studies suggested that ORAI3 is a weak SOCC subunit [199, 
200]. DeHaven et al reported that current of SOCE in HEK cells with co-expression 
of STIM1 and 0RAI1, or STIM1 and ORAI2, was significantly larger than that of 
STIM1 and ORAI3 [199]. Similar result was reported by Schindl et aL; ORAI3 
reduced the current in HEK cells that were transfected with STIM1 and 0RAI1 
[200]. In our study, ORAI3 was down-regulated by applying E2. We hypothesized 
that this may reduce the existence of ORAI3 homomer and ORAIl-ORAI3 
heteromer. The reduction in ORAIl-ORAI3 heteromer can release more 0RAI1 
subunits for the formation of 0RAI1 homomer, which can conduct a stronger SOCE. 
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Therefore, formation of more ORAI 1 homomer may be able to compensate the loss 
of ORAIl-ORAI3 heteromer and ORAI3 homomer, resulting in a net increase in 
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4.5 Experiments Aiming to Knockdown ORAI3 
Knockdown of ORAI3 by siRNA was carried out in order to examine whether a 
decrease in ORAI3 expression would lead to an increase in SOCE, as what we 
observed from the action of E2. From our results, ORAI3 could be successfully 
knocked-down in mESCs after 3 days of transfection, however, the knockdown 
effect was vanished once the transfected cells subjected to trypsinization within the 3 
days of transfection. 
Interestingly, the expression level of ORAI3 decreased from 48 hours to 72 
hours after transfection (n=3). This hints that expression level of ORAI3 may be 
negatively correlated with cell density. If this is true, cell trypsinization after 2 days 
of transfection would lead to a decrease in cell density and hence increase the 
expression level of ORAI3, therefore this would counteract the knockdown effect 
carried by the siRNA. 
In order to prove our hypothesized model is true, we should confirm the 
existence of those homomer and heteromer in mESCs, as well as examine the 
ORAI3 expression in membrane fraction. Also, fluorescence resonance energy 
transfer (FRET) could be used to examine if down-regulation of ORAI3 homomers 
and up-regulation of 0RAI1 homomers occur after E2 treatment. 
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4.6 Proposed Mechanism to Show an Increment of SOCE by Other SOCC 
Candidates Rather than ORAI3 
Although expression level of other SOCC candidates remained unchanged after 
E2 treatment, these channels may undergo post-translational modification and hence 
increase channel activity. As mentioned before, TRPC1 was one of the most 
abundantly expressed TRPC candidates in mESCs, and this may be one of the 
downstream targets of E2 in our current study. Numerous reports showed that 
caveolin-1 (principle molecule in caveolae) interacts with TRPC1 and regulates 
TRPC activity [201-203]. It is suggested that caveolin-1 holdsJRPCl , I P 3 R and G 
protein-coupled receptor in a tight spatial organization so that TRPC1 can be 
activated efficiently [204]. Recently, Park et al demonstrated that E2 stimulated 
expression and phosphorylation of caveolin-1 in mESCs, and this led to enhanced 
proliferation of mESCs [205]. By the aforementioned reports, we hypothesized that 
E2 up-regulates the expression of caveolin-1 in mESCs and hence increases the level 
of functional TRPC1, finally leads to an increase in SOCE. 
In the future, we should examine whether TRPC1 is a SOCC in piESCs by 
using siRNA, and blocking antibody which serves as specific blocker to abolish 
TPRC1 activity [112]. Also, protein-protein interaction between TRPC1 and 
caveolin-1 in mESCs should be confirmed. 
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4.7 Activation of NFATc3 and NFATc4 by E2 in mESCs 
As CsA could reverse the stimulatory effect of E2 on mESCs proliferation, 
NFATs were believed to be one of the candidates responsible for this phenomenon. 
Previous study from our lab demonstrated that several NFAT isoforms, NFATc2, 
NFATc3 and NFATc4 were expressed in mESCs at mRNA level. Since it had been 
reported that NFATc2 showed tumor suppressor properties, while NFATc3 and 
NFATc4 acted as proliferation inductors [171], only the roles of NFATc3 and 
NFATc4 in maintaining self-renewal properties of mESCs were investigated in the 
present study. „ 
Activation of endogenous NFATc3 by E2 was examined by using westem blot. 
A faster electromobility shift ofbands could be observed when cell lysates/cells were 
subjected to CIP- and ionomycin-treatment, while a slower electromobility shift of 
bands was observed upon CsA-treatment. Since the results from these positive 
controls were the same as what we expected, we believed that westem blot was a 
valid tool to study the effect of E2 on regulating NFATc3 phosphorylation status. 
From our results, more de-phosphorylated form of NFATc3 in mESCs were found 
upon E2 treatment after 20 hour, and this effect could be reversed by 2-APB 
(0.3^M), suggesting that activation ofNFATc3 by E2 was mediated by increment of 
SOCE. ‘ 
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However, CsA at 3 ^M showed no significant effect on the proliferation on 
mESCs, while it caused significant phosphorylation of NFATc3. This may be 
explained by the possibility that the basal activity o fNFATc3 was too low, therefore 
even a significant phosphorylation of NFATc3 would not lead to a decrease in 
proliferation. Also, the phosphorylation pattems o fNFATc3 between 2-APB-treated 
groups and control were similar, and this may be due to that basal SOCE in mESCs 
was too low to activate NFATc3, therefore a high concentration of 2-APB (10，100 
^M) could not affect the phosphorylation status ofNFATc3. 
But upon treatment of E2, SOCE was enhanced so that it may trigger the 
activity of NFATc3, therefore more de-phosphorylated form of NFATc3 could be 
observed and could be reversed by low concentration of2-APB (0.3^iM). 
For the case in NFATc4, we failed to observe any change in phosphorylation 
status under treatment of CIP, ionomycin, and CsA by using westem blot analyses. 
This may be explained by the quality of two NFATc4 antibodies did not allow us to 
observe different phosphorylated-forms of NFATc4, and therefore immunostaining 
was not considered. Instead, we used NFATc4-GFP as a tool to study the effect of 
E2 on the nuclear translocation of NFATc4. By using fluorescence microscopy, the 
N/C ratio of fluorescence signal was measured. The ratio increased after application 
of E2 to mESCs after 8 hours, and this could be reversed by 2-APB (0.3^iM). This 
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suggested that nuclear translocation ofNFATc4 occurred in E2-treated cells, and this 
was mediated through SOCE. However, it should be noticed that the results from this 
part of experiment only reflect the effect o fE2 on over-expressed NFATc4; whether 
endogenous NFATc4 behaves the same remains unknown. 
4.8 Possible Downstream Targets of NFAT Responsible for E2-induced 
mESCs Proliferation 
Cytokines are one of the major target genes ofNFAT in various cell types [152]. 
In mESCs, several types of cytokines were found to be „ released, including 
interleukins (IL), growth factors, chemokines, etc [206, 207]. Also, it is well-known 
that proliferation of mESCs is dependent on the presence of leukaemia inhibitory 
factor (LIF), an interleukin-6 (IL-6) class cytokine, which can activate heteromeric 
receptor LIFR/gpl30 on cell surface for signal transduction [208]. However, there is 
no report showing that the expression of those mESCs-released cytokines is under 
the control ofNFAT. 
Apart from cytokines, cell cycle regulatory proteins (cyclins，CDK, etc.) are 
also targets of NFAT as had been reported elsewhere [156, 169，172, 173]. 
Interesting, proliferation of mESCs could be stimulated by applying extrinsic factors 
such as E2 [52], adenosine triphosphate [209], angiotensin II [71], or epidermal 
96 
growth factor [72], which involved the up-regulation of cyclin D1 for favoring Gi/S 
phase transition. Another report showed that application of phosphatidylinositol 
3-kinase inhibitor reduced proliferation of mESCs, decreased the expression of 
cyclin D1, and arrested cell cycle at Gi phase [210]. The above data suggested that 
there is a positive relationship between expression level of cyclin D1 and 
proliferation rate of mESCs. Therefore, we considered cell cycle regulatory proteins 
are another possible NFAT-downstream targets that are responsible for E2-induced 
mESCs proliferation. 
Meanwhile, knockdown of NFATc3 reduced proliferation of human vascular 
smooth muscle cells and down-regulated expression of cyclin D1 [211]. While 
NFATc4 was involved in the induction of cyclin D1 expression by polycyclic 
aromatic hydrocarbons and ionic radiation in mouse epidermal cells [96]. These 
results implied that both NFATc3 and NFATc4 could induce the expression of cyclin 
D1. Therefore, it is possible that cyclin D1 may be a downstream target ofNFATs in 
E2-induced mESCs proliferation. 
In order to test if NFATc3 or NFATc4 can induce cyclin D1 expression in 
mESCs, plasmid harboring cyclin D1 promoter driving luciferase expression and 
either NFATc3 or NFATc4 plasmid can be co-transfected into mESCs for measuring 
luciferase activity. 
97 
CHAPTER FIVE FUTURE PERSPECTIVES 
In the present study, we were the first group to demonstrate roles of SOCE in 
maintaining self-renewal and proliferation properties of mESCs. The results enrich 
our knowledge on basic ESC biology and further raise up more questions on how 
2_j_ 
Ca regulate cell physiology of mESC. 
Roles of ORAI3 in maintaining SOCE and regulating cell physiology are poorly 
understood. In our study, down-regulation of ORAI3 was found to be correlated to 
an increase in SOCE in mESCs. Therefore, we would like to optimize the condition 
for ORAI3 knockdown experiments so as to examine whether a reduction of ORAI3 
n 
expression can lead to an increase in SOCE in mESCs. Also, ORAI3 expression in 
membrane fraction of E2-treated mESCs will be studied. Furthermore, FRET 
experiment can be carried out to study if down-regulation of ORAI3 homomers 
and/or up-regulation of 0RAI1 homomers occur upon E2 treatment. 
Also, it would be interesting to know whether TRPC1 is a SOCC player in 
mESCs, and if TRPC1 is related to self-renewal property of mESCs. Specific 
blocking antibody and siRNA could be used to study the functions of TRPC1 in 
*» 
mESCs. 
In present study, NFATc3 had been demonstrated to be a downstream target of 
E2-enhanced SOCE. In order to further support this finding, immunostaining of 
NFATc3 could be carried out for examining if nuclear translocation of NFATc3 
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occurs upon treatment of lnM E2. 
Up-regulation of cyclin D1 had been proposed as the results of activation of 
NFATc3 and NFATc4, and this event would likely lead to increase in proliferation of 
mESCs. Therefore, we would like to study ifNFATc3 or NFATc4 can directly induce 
the expression of cyclin D1 in mESCs by co-transfection of NFAT plasmid and 




CHAPTER SIX CONCLUSION 
^ 1 
The roles of Ca of maintaining self-renewal characteristics of mESCs were 
examined in the present study. The project aims to determine if SOCE is related to 
self-renewal property of mESCs, to examine if E2 acts as extrinsic factor to regulate 
proliferation mediated by SOCE, and to identify ifNFATs are the downstream targets 
ofSOCE in mESCs. 
The functional and molecular expressions of SOCE in mESCs were confirmed 
by using confocal microscopy and RT-PCR (Figure 24, (A)). Meanwhile, by using 
SOCC blockers La)+ and 2-APB, proliferation rate of mESCs was significantly 
reduced and pluripotency marker Sox-2 was down-regulated by 100^M 2-APB, 
suggesting that SOCE is related to self-renewal properties of mESCs (Figure 24, 
(B)). 
E2 was found to be an extrinsic factor which could stimulate proliferation of 
mESCs, and this effect could be reversed by co-treatment with 0.3^M 2-APB, 
suggesting that 2-APB sensitive pathway was involved in E2-induced proliferation. 
Meanwhile, amplitude of SOCE was found to be enhanced by lnM E2 and could be 
reversed by 0.3^M 2-APB, this data strongly confirmed that E2-induced mESCs 
proliferation was mediated by increment ofSOCE (Figure 24, (C)). 
Measurement of relative expression of SOCC candidates between E2-treated 
100 
and control group was carried out in order to examine the mechanism behind 
E2-induced enhancement of SOCE. ORAI3 was down-regulated at both mRNA and 
protein level by applying lnM E2, while mRNA expression levels of other SOCC 
candidates were unchanged (Figure 24, (D)). By using siRNA technology, ORAI3 
could be successfully knocked-down in mESCs after 72 hours of transfection. 
However, more optimization is needed for testing if knockdown of ORAI3 can lead 
to increase in SOCE. 
Experiments were done for examine the relationship between SOCE and 
proliferation of mESCs. By using western blot, more de-phosphorylated NFATc3 
(active form) was found upon lnM E2 treatment, and this could be reversed by 
co-treatment with 0.3^iM 2-APB. At the same time, by using fluorescence 
microscopy, nuclear translocation of GFP-NFATc4 by lnM E2 was observed, and 
again this could be reversed by 0.3 ^M 2-APB. These data implied that NFATc3 and 
GFP-NFATc4 were the downstream targets of E2-induced enhancement of SOCE 
(Figure 25). 
Furthermore, inhibition of NFAT proteins by CsA was shown to reverse the 
proliferative effect by lnM E2, showing that NFAT activity was crucial to carry out 
the enhanced proliferation effect (Figure 24，(E)) 
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Figure 24. Schematic diagram summarizing the findings of the present study. (A) 
Functional and molecular expression of SOCE in mESCs; (B) SOCC blockers 
inhibited SOCE and self-renewal property of mESCs; (C) E2 stimulated proliferation 
of mESCs via increment of SOCE; (D) Expression of ORAI3 was down-regulated 
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1. Evans, M.J. and M.H. Kaufman, Establishment in culture of pluripotential 
cells from mouse embryos. Nature, 1981. 292(5819): p. 154-6. 
2. Martin, G.R., Isolation ofa pluripotent cell line from early mouse embryos 
cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl 
Acad Sci U S A, 1981. 78(12): p. 7634-8. 
3. Ebert, A.D. and C.N. Svendsen, Human stem cells and drug screening: 
opportunities and challenges. Nat Rev Drug Discov. 9(5): p. 367-72. 
4. Schindehutte, J., W. Paulus, and A. Mansouri, [Stem cell therapy in 
Parkinson disease]. Pharm Unserer Zeit, 2006. 35(3): p. 250-4. 
5. Lindvall, 0 . , Parkinson disease. Stem cell transplantation. Lancet, 2001. 358 
SuppI: p. S48. 
6. Dimmeler, S., J. Burchfield, and A.M. Zeiher, Cell-based therapy of 
myocardial infarction. Arterioscler Thromb Vasc Biol, 2008. 28(2): p. 
208-16. 
7. Lee, M.S. and R.R. Makkar, Stem-cell transplantation in myocardial 
infarction: a status report. Ann Intem Med, 2004. 140(9): p. 729-37. 
8. Hussain, M.A. and N.D. Theise, Stem-cell therapy for diabetes mellitus. 
Lancet, 2004. 364(9429): p. 203-5. 
9. Urban, S.V., et al., [Stem cell therapy for diabetes mellitus: progress, 
prospects and challenges]. Orv Hetil, 2006. 147(17): p. 791-7. 
10. Fujikawa, T.，et al., Teratoma formation leads to failure of treatment for type 
I diabetes using embryonic stem cell-derived insulin-producing cells. Am J 
Pathol, 2005. 166(6): p. 1781-91. 
11. Nussbaum, J., et al., Transplantation of undifferentiated murine embryonic 
stem cells in the heart: teratoma formation and immune response. FASEB J, 
2007.21(7): p. 1345-57. 
12. Heldring, N., et al., Estrogen receptors: how do they signal and what are 
their targets. Physiol Rev, 2007. 87(3): p. 905-31. 
13. Kato, S., Function of estrogen receptor (ER) in gene expression. Jpn J Clin 
Oncol, 1999. 29(7): p. 321-2. 
14. Kushner，P.J., et al., Estrogen receptor pathways to AP-1. J Steroid"Biochem 
Mol Biol,2000. 74(5): p.311-7. 
15. Saville, B., et al., Ligand-, cell-, and estrogen receptor subtype 
(alpha/beta)-dependent activation at GC-rich (Spl) promoter elements. J 
Biol Chem, 2000. 275(8): p. 5379-87. 
16. Metivier, R., et .al., Function of N-terminal transactivation domain of the 
estrogen receptor requires a potential alpha-helical structure and is 
104 
negatively regulated by theA domain. Mol Endocrinol, 2000. 14(11): p. 
1849-71. 
17. Tremblay, G.B., et al., Dominant activity of activation function 1 (AF-I) and 
differential stoichiometric requirements forAF-1 and -2 in the estrogen 
receptor alpha-beta heterodimeric complex. Mol Cell Biol, 1999. 19(3): p. 
1919-27. 
18. Mader, S., P. Chambon, and J.H. White, Defining a minimal estrogen 
receptor DNA binding domain. Nucleic Acids Res, 1993. 21(5): p. 1125-32. 
19. Nardulli, A.M. and D.J. Shapiro, Binding of the estrogen receptor 
DNA-binding domain to the estrogen response element induces DNA bending. 
Mol Cell Biol, 1992. 12(5): p. 2037-42. 
20. Qiu, J., et al., Estrogen upregulates T-type calcium channels in the 
hypothalamus and pituitary. J Neurosci, 2006. 26(43): p. 11072-82. 
21. Perez-Reyes, E., Molecular physiology of low-voltage-activated t-type 
calcium channels. Physiol Rev, 2003. 83(1): p. 117-61. 
22. Brewer, L.D.，et al., Estradiol reverses a calcium-related biomarker of brain 
aging in female rats. J Neurosci, 2009. 29(19): p. 6058-67. 
23. Johnson, B.D., et al., Increased expression of the cardiac L-type calcium 
channel in estrogen receptor-deficient mice. J Gen Physiol, 1997.110(2): p. 
135-40. 
24. Gilligan, D.M., A.A. Quyyumi, and R.0. Cannon, 3rd, Effects of 
physiological levels of estrogen on coronary vasomotor function in 
postmenopausal women. Circulation, 1994. 89(6): p. 2545-51. 
25. Chang, A.S., et al., Concomitant and hormonally regulated expression of trp 
genes in bovine aortic endothelial cells. FEBS Lett, 1997. 415(3): p. 335-40. 
26. Bolanz，K.A., M,A. Hediger, and C.P. Landowski, The role ofTRPV6 in 
breast carcinogenesis. Mol Cancer Ther, 2008. 7(2): p. 271-9. 
27. Cato, A.C., A. Nestl, and S. Mink, Rapid actions of steroid receptors in 
cellular signaling pathways. Sci STKE, 2002. 2002(138): p. re9. 
28. Ho, K.J. and J.K. Liao, Nonmclear actions of estrogen. Arterioscler Thromb 
Vasc Biol, 2002. 22(12): p. 1952-61. 
29. Simoncini, T. and A.R. Genazzani, Non-genomic actions of sex steroid 
hormones. Eur J Endocrinol, 2003. 148(3): p. 281-92. 
30. Edwards, D.P., Regulation ofsignal transduction pathways by estrogen and 
progesterone. Annu Rev Physiol, 2005. 67: p. 335-76. 
31. Meyer, R., et al., Rapid modulation of L-type calcium current by acutely 
applied oestrogens in isolated cardiac myocytes from human, guinea-pig and 
rat. Exp Physiol, 1998. 83(3): p. 305-21. 
105 
32. Jiang, C.，et al., Effect of 17 beta-oestradiol on contraction, Ca2+ current 
and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J 
Pharmacol, 1992. 106(3): p. 739-45. 
33. Zhang, R, et al., 17 beta-Estradiol attenuates voltage-dependent Ca2+ 
currents in A 7r5 vascular smooth muscle cell line. Am J Physiol, 1994. 266(4 
P t l ) : p . C975-80. 
34. Nakajima, T., et al., 17beta-Estradiol inhibits the voltage-dependent L-type 
Ca2+ currents in aortic smooth muscle cells. Eur J Pharmacol, 1995. 
294(2-3): p. 625-35. 
35. Townsend, E.A., et al., Rapid effects of estrogen on intracellular Ca2+ 
regulation in human airway smooth muscle. Am J Physiol Lung Cell Mol 
Physiol. 298(4): p. L521-30. 
36. Mermelstein, P.G, J.B. Becker, and D.J. Surmeier, Estradiol reduces calcium 
currents in rat neostriatal neurons via a membrane receptor. J Neurosci, 
1996. 16(2): p. 595-604. 
37. Lee, D.Y., et al., 17Beta-estradiol inhibits high-voltage-activated calcium 
channel currents in rat sensory neurons via a non-genomic mechanism. Life 
Sci, 2002. 70(17): p. 2047-59. ‘ 
38. Tesarik, J. and C. Mendoza, Nongenomic effects of 17 beta-estradiol on 
maturing human oocytes: relationship to oocyte developmental potential J 
Clin Endocrinol Metab, 1995. 80(4): p. 1438-43. 
39. Wu, T.W., et al., 17Beta-estradiol induced Ca2+ influx via L-type calcium 
channels activates the Src/ERK/cyclic-AMP response element binding protein 
signal pathway and BCL-2 expression in rat hippocampal neurons: a 
potential initiation mechanism for estrogen-induced neuroprotection. 
Neuroscience, 2005.135(1): p. 59-72. 
40. Picotto, G.，V. Massheimer, and R. Boland, Acute stimulation of intestinal cell 
calcium influx induced by 17 beta-estradiol via the cAMP messenger system. 
Mol Cell Endocrinol, 1996. 119(2): p, 129-34. 
41. Chaban, V.V., A.J. Lakhter, and P. Micevych, A membrane estrogen receptor 
mediates intracellular calcium release in astrocytes. Endocrinology, 2004. 
145(8): p. 3788-95. ‘ 
42. Micevych, P.E., et al., Estradiol stimulates progesterone synthesis in 
hypothalamic astrocyte cultures. Endocrinology, 2007. 148(2): p. 782-9. 
43. Abe, H., K.L. Keen, and E. Terasawa, Rapid action of estrogens on 
intracellular calcium oscillations in primate luteinizing hormone-releasing 
hormone-1 neurons. Endocrinology, 2008. 149(3): p. 1155-62. 
44. Gorski, J. and Q. Hou, Embryonic estrogen receptors: do they have a 
106 
physiological function? Environ Health Perspect, 1995. 103 Suppl 7: p. 
69-72. 
45. Hou, Q., et al., Immunolocalization of estrogen receptor protein in the mouse 
blastocyst during normal and delayed implantation. Proc Natl Acad Sci U S 
A, 1996. 93(6): p. 2376-81. 
46. Bartholomeusz, R.K., N.W. Bruce, and A.M. Lynch, Embryo survival, and 
fetal and placental growth following elevation of maternal estradiol blood 
concentrations in the rat. Biol Reprod, 1999. 61(1): p. 46-50. 
47. Csapo, A.I. and W.G Wiest, Plasma steroid levels and ovariectomy-induced 
placental hypertrophy in rats. Endocrinology, 1973. 93(5): p. 1173-7. 
48. Fatum, M., et al., Is estradiol mandatory for an adequate follicular and 
embryo development? A mouse model using aromatase inhibitor 
(anastrozole). J Assist Reprod Genet, 2006. 23(11-12): p. 407-12. 
49. Couse, J.F. and K.S. Korach, Estrogen receptor null mice: what have we 
learned and where will they lead us? Endocr Rev, 1999. 20(3): p. 358-417. 
50. Tielens, S.，et al., Effect of 17beta-estradiol on the in vitro differentiation of 
murine embryonic stem cells into the osteogenic lineage. In Vitro Cell Dev 
Biol Anim, 2008. 44(8-9): p. 368-78. “ 
51. Murashov, A.K., et al., 17beta-Estradiol enhances neuronal differentiation of 
mouse embryonic stem cells. FEBS Lett, 2004. 569(1-3): p. 165-8. 
52. Han, HJ. , J.S. Heo, and Y.J. Lee, Estradiol-17beta stimulates proliferation of 
mouse embryonic stem cells: involvement of MAPKs and CDKs as well as 
protooncogenes. Am J Physiol Cell Physiol, 2006. 290(4): p. C1067-75. 
53. Verdier-Sevrain, S., et al., Estradiol induces proliferation ofkeratinocytes via 
a receptor mediated mechanism. FASEB J, 2004. 18(11): p. 1252-4. 
54. Foidart, J.M., et al., Estradiol and progesterone regulate the proliferation of 
human breast epithelial cells, Fertil Steril, 1998. 69(5): p. 963-9. 
35. Zhu, L. and J.W. Pollard, Estradiol-17beta regulates mouse uterine epithelial 
cell proliferation through insulin-like growth factor 1 signaling. Proc Natl 
Acad Sci U S A, 2007. 104(40): p. 15847-51. 
56. Santen, R., et al., Estrogen mediation ofbreast tumor formation involves 
estrogen receptor-dependent, as well as independent, genotoxic effects. Ann 
N Y Acad Sci, 2009. 1155: p. 132-40. 
57. Santen, R.J., et al., Adaptation to estradiol deprivation causes up-regulation 
ofgrowth factor pathways and hypersensitivity to estradiol in breast cancer 
cells. Adv Exp Med Biol, 2008. 630: p. 19-34. 
58. Renoir, J.M., et al., Antioestrogen-mediated cell cycle arrest and apoptosis 
induction in breast cancer and multiple myeloma cells. J Mol Endocrinol, 
107 
2008. 40(3): p. 101-12. 
59. Russo, J. and I.H. Russo, The role of estrogen in the initiation of breast 
cancer. J Steroid Biochem Mol Biol, 2006. 102(1-5): p. 89-96. 
60. Song, R.X. and R.J. Santen, Membrane initiated estrogen signaling in breast 
cancer. Biol Reprod, 2006. 75(1): p. 9-16. 
61 • Marino, M.，et al., Distinct nongenomic signal transduction pathways 
controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene 
transcription in HepG2 cells. Mol Biol Cell, 2002. 13(10): p. 3720-9, 
62. Berridge, M.J., P. Lipp, and M.D. Bootman, The versatility and universality 
of calcium signalling. Nat Rev Mol Cell Biol, 2000. 1(1): p. 11-21. 
63. Clapham, D.E., Calcium signaling. Cell, 1995. 80(2): p. 259-68. 
64. Bootman, M.D. and P. Lipp, Ringing changes to the 'bell-shapedcurve'. Curr 
Biol, 1999. 9(23): p. R876-8. 
65. Berridge, M.J.，Inositol trisphosphate and calcium signalling. Nature, 1993. 
361(6410):p.315-25. 
66. Yanagida, E., et al., Functional expression of Ca2+ signaling pathways in 
mouse embryonic stem cells. Cell Calcium, 2004. 36(2): p. 135-46. 
67. Wang, K., et al., Electrophysiological properties of plunpotent human and 
mouse embryonic stem cells. Stem Cells, 2005. 23(10): p. 1526-34. 
68. Kapur, N., G.A. Mignery, and K. Banach, Cell cycle-dependent calcium 
oscillations in mouse embryonic stem cells. Am J Physiol Cell Physiol, 2007. 
292(4):p.C1510-8. 
69. Kim, Y.H. and H.J. Han, High-glucose-induced prostaglandin E(2) and 
peroxisome proliferator-activated receptor delta promote mouse embryonic 
stem cellproliferation. Stem Cells, 2008. 26(3): p. 745-55. 
70. Jeong, A.Y., et al., PPARdelta agonist-mediated ROS stimulates mouse 
embryonic stem cell proliferation through cooperation of p38 MAPK and 
Wnt/beta-catenin. Cell Cycle, 2009. 8(4): p. 611-9. 
71. Han, H.J., et al., ANG II-stimulated DNA synthesis is mediated by ANGII 
receptor-dependent Ca(2+)/PKC as well as EGF receptor-dependent 
PI3K/Akt/mTOR/p 70S6K1 signal pathways in mouse embryonic stem cells. J 
Cell Physiol, 2007. 211(3): p. 618-29. ‘ 
72. Heo, J.S., Y.J. Lee, and H.J. Han, EGF stimulates proliferation of mouse 
embryonic stem cells: involvement of Ca2+ influx andp44/42 MAPKs. Am J 
Physiol Cell Physiol, 2006. 290(1): p. C123-33. 
73. Schwirtlich, M., et al., GABA(A) and GABA(B) receptors ofdistinct 
propertiesaffect oppositely the proliferation of mouse embryonic stem cells 
through synergistic elevation ofintracellular Ca(2+). FASEB J. 24(4): p. 
108 
1218-28. 
74. Ryu, J.M., et al.，Zinc chloride stimulates DNA synthesis of mouse embryonic 
stem cells: involvement of PI3K/Akt, MAPKs, andmTOR. J Cell Physiol, 
2009. 218(3): p. 558-67. 
75. Heo, J.S., S.H. Lee, and H.J. Han, Regulation of DNA synthesis in mouse 
embryonic stem cells by transforming growth factor-alpha: involvement of 
the PI3-K/Akt and Notch/Wnt signaling pathways. Growth Factors, 2008. 
26(2): p. 104-16. 
76. Kim, M.O., et al., Epinephrine increases DNA synthesis via ERKl/2s through 
cAMP, Ca(2+)/PKC, and PI3K/Akt signaling pathways in mouse embryonic 
stem cells. J Cell Biochem，2008. 104(4): p. 1407-20. 
77. Zeng, W., et al., STIM1 gates TRPC channels, but not Orail, by electrostatic 
interaction. Mol Cell, 2008. 32(3): p. 439-48. 
78. Kim, Y.H. and H.J. Han, Synergistic effect of high glucose and ANGII on 
proliferation ofmouse embryonic stem cells: involvement of PKC and 
MAPKs as well asATl receptor. J Cell Physiol, 2008. 215(2): p. 374-82. 
79. Heo, J.S., M.Y. Lee, and H.J. Han, Sonic hedgehog stimulates mouse 
embryonic stem cell proliferation by cooperation of Ca2'+/protein kinase C 
and epidermal growth factor receptor as well as Glil activation. Stem Cells, 
2007. 25(12): p. 3069-80. 
80. Parekh, A.B. and J.W. Putney, Jr., Store-operated calcium channels. Physiol 
Rev, 2005. 85(2): p. 757-810. 
81. Venkatachalam, K., et al., The cellular and molecular basis of store-operated 
calcium entry. Nat Cell Biol, 2002. 4(11): p. E263-72. 
82. Leung, F.R, et al., Store-operated calcium entry in vascular smooth muscle. 
Br J Pharmacol, 2008. 153(5): p. 846-57. 
83. Cuddon, P., et al., Methacholine and PDGF activate store-operated calcium 
entry in neuronal precursor cells via distinct calcium entry channels. Biol 
Res, 2008. 41(2): p. 183-95. 
84. Ma, R. and S.C. Sansom, Epidermal growth factor activates store-operated 
calcium channels in human glomerular mesangial cells. J Am Soc Nephrol, 
2001. 12(1): p. 47-53. ‘ 
85. Wang, Q., et al., IL-1 induced release of Ca2+from internal stores is 
dependent on cell-matrix interactions and regulates ERK activation. FASEB 
J，2003. 17(13):p. 1898-900. 
86. Trepakova, E.S., et al., Calcium influx factor directly activates store-operated 
cation channels in vascular smooth muscle cells. J Biol Chem, 2000. 275(34): 
p. 26158-63. 
109 
87. Albert, A.P. and W.A. Large, Store-operated Ca2+-permeable non-selective 
cation channels in smooth muscle cells. Cell Calcium, 2003. 33(5-6): p. 
345-56. 
88. Cao, Y. and J.Y. Chatton, Involvement of calmodulin in the activation of 
store-operated Ca2+ entry in rat hepatocytes, FEBS Lett, 1998. 424(1-2): p. 
33-6. 
89. Putney, J.W., Jr., A model for receptor-regulated calcium entry. Cell Calcium, 
1986. 7( l ) :p . 1-12. 
90. Patterson, R.L., D.B. van Rossum, and D.L. Gill, Store-operated Ca2+ entry: 
evidence for a secretion-like coupling model. Cell, 1999. 98(4): p. 487-99. 
91. Yao, Y.，et al., Activation of store-operated Ca2+ current in Xenopus oocytes 
requires SNAP-25 but not a diffusible messenger. Cell, 1999. 98(4): p. 
475-85. 
92. Liou, J., et al., STIM is a Ca2+ sensor essential for 
Ca2+-store-depletion-triggeredCa2+ influx. Curr Biol, 2005. 15(13): p. 
1235-41. 
93. Roos, J., et al., STIM1, an essential and conserved component of 
store-operatedCa2+ channel function. J Cell Biol, 2005. 169(3): p. 435-45. 
94. Feske, S., et al., A mutation in Orail causes immune deficiency by abrogating 
CRAC channelfunction. Nature, 2006. 441(7090): p. 179-85. 
95. Vig, M., et al., CRACM1 is a plasma membrane protein essential for 
store-operatedCa2+ entry. Science, 2006. 312(5777): p. 1220-3. 
96. Ding, J., et al., Involvement of nuclear factor of activatedTcells 3 fl^FAT3) 
in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in 
mouse epidermal Cl 41 cells. Mol Cell Biochem, 2006. 287(1-2): p. 117-25. 
97. Lis, A.，et al.，CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ 
channels with distinct functional properties. Curr Biol, 2007. 17(9): p. 
794-800. 
98. Liou, J., et al., Live-cell imaging reveals sequential oligomerization and local 
plasma membrane targeting of stromal interaction molecule 1 after Ca2+ 
store depletion. Proc Natl Acad Sci U S A，2007. 104(22): p. 9301-6. 
99. Muik, M., et al., Dynamic coupling of the putative coiled-coil domain of 
ORAIl with STIM1 mediates 0RAI1 channel activation. J Biol Chem, 2008. 
283(12): p. 8014-22. 
100. Wu, M.M., et al., Ca2^ store depletion causes STIM1 to accumulate in ER 
regions closely associated with the plasma membrane. J Cell Biol, 2006. 
174(6): p. 803-.13. 
101. Zhang, S 1 . , et al.，STIM1 is a Ca2+ sensor that activates CRAC channels 
110 
and migrates from the Ca2+ store to the plasma membrane. Nature, 2005. 
437(7060): p. 902-5. 
102. Luik, R.M., et al., The elementary unit of store-operated Ca2+ entry: local 
activation of CMC channels by STIMl at ER-plasma membrane junctions. J 
Cell Biol, 2006. 174(6): p.815-25. 
103. Wes, P.D., et al., TRPC1, a human homolog of a Drosophila store-operated 
channel Proc Natl Acad Sci U S A, 1995. 92(21): p. 9652-6. 
104. Zhu, X.，et al., Molecular cloning of a widely expressed human homologue 
for the Drosophila trpgene. FEBS Lett, 1995. 373(3): p. 193-8. 
105. Montell, C., et al., A unified nomenclature for the superfamily ofTRP cation 
channels. Mol Cell, 2002. 9(2): p. 229-31. 
106. Zitt, C., et al., Cloning and functional expression of a human 
Ca2+-permeable cation channel activated by calcium store depletion. 
Neuron, 1996. 16(6): p. 1189-96. 
107. Zagranichnaya, T.K., X. Wu, and M.L. Villereal, Endogenous TRPC1, 
TRPC3, and TRPC7 proteins combine to form native store-operated channels 
in HEK-293 cells. J Biol Chem, 2005. 280(33): p. 29559-69. 
108. Wu, X., G. Babnigg, and M.L. Villereal, Functional significance ofhuman 
trpl and trp3 in store-operated Ca(2+) entry in HEK-293 cells. Am J Physiol 
Cell Physiol, 2000. 278(3): p. C526-36. 
109. Lintschinger, B.，et al., Coassembly ofTrpl and Trp3 proteins generates 
diacylglycerol- and Ca2+-sensitive cation channels. J Biol Chem, 2000. 
275(36): p. 27799-805. 
110. Strubing, C., et al., TRPC1 and TRPC5form a novel cation channel in 
mammalian brain. Neuron, 2001. 29(3): p. 645-55. 
111 • Strubing, C., et al., Formation of novel TRPC channels by complex subunit 
interactions in embryonic brain. J Biol Chem, 2003. 278(40): p. 39014-9. 
112. Kwan, H.Y., et al., TRPC1 associates with BK(Ca) channel toform a signal 
complex in vascular smooth muscle cells. Circ Res, 2009. 104(5): p. 670-8. 
113. Rosker, C.，et al., Ca(2+) signaling by TRPC3 involves Na(+) entry and local 
coupling to the Na(+)/Ca(2+) exchanger. J Biol Chem, 2004. 279(14): p. 
13696-704. ‘ 
114. Yuan, J.P., et al., STIMl heteromultimerizes TRPC channels to determine 
their function as store-operated channels. Nat Cell Biol, 2007. 9(6): p. 
636-45. 
115. Peinelt, C., et al., Amplification of CRAC current by STIMl and CRACM1 
(Orail). Nat Cell Biol, 2006. 8(7): p. 771-3. 
116. Soboloff, J., et al., Orail and STIMreconstitute store-operated calcium 
111 
channel function. J Biol Chem, 2006. 281(30): p. 20661-5. 
117. Mercer, J.C., et al., Large store-operated calcium selective currents due to 
co-expression ofOrail or Orai2 with the intracellular calcium sensor, Stiml. 
J Biol Chem, 2006. 281(34): p. 24979-90. 
118. Ohba, T., et al., Upregulation ofTRPCJ in the development of cardiac 
hypertrophy. J Mol Cell Cardiol, 2007. 42(3): p. 498-507. 
119. Bush, E.W., et al., Canonical transient receptor potential channels promote 
cardiomyocyte hypertrophy through activation of calcineurin signaling. J 
Biol Chem, 2006. 281(44): p. 33487-96. 
120. Wang, J.，et al., Hypoxia inducible factor 1 mediates hypoxia-induced TRPC 
expression and elevated intracellular Ca2+ in pulmonary arterial smooth 
muscle cells. Circ Res, 2006. 98(12): p. 1528-37. 
121. Lin, M.J., et al., Chronic hypoxia-induced upregulation of store-operated and 
receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: 
a novel mechanism ofhypoxic pulmonary hypertension. Circ Res, 2004. 
95(5): p. 496-505. 
122. White, T.A., et al., Role of transient receptor potential C3 in 
TNF-alpha-enhanced calcium influx in human airway myocytes. Am J Respir 
Cell Mol Biol, 2006. 35(2): p. 243-51. 
123. Bae, Y.M., et al., Enhancement of receptor-operated cation current and 
TRPC6 expression in arterial smooth muscle cells of deoxycorticosterone 
acetate-salt hypertensive rats. J Hypertens, 2007. 25(4): p. 809-17. 
124. Dalrymple, A., et al., Physiological induction of transient receptor potential 
canonical proteins, calcium entry channels, in human myometrium: influence 
ofpregnancy, labor, and interleukin-1 beta. J Clin Endocrinol Metab, 2004. 
89(3): p. 1291-300. 
125. Abramowitz, J. and L. Birnbaumer, Physiology and pathophysiology of 
canonical transient receptor potential channels. FASEB J, 2009. 23(2): p. 
297-328. 
126. Firth,八丄.，C.V. Remillard, and J.X. Yuan, TRP channels in hypertension. 
Biochim Biophys Acta, 2007. 1772(8): p. 895-906. 
127. Nilius, B., et al., Transient receptor potential cation channels in disease. 
Physiol Rev, 2007. 87(1): p. 165-217. 
128. Guinamard, R. and P. Bois, Involvement of transient receptor potential 
proteins in cardiac hypertrophy. Biochim Biophys Acta, 2007. 1772(8): p. 
885-94. 
129. Venkatachalam, K. and C. Montell, TRP channels. Annu Rev Biochem, 2007. 
76:p.387-417. 
112 
130. Nilius, B., T. Voets, and J. Peters, TRP channels in disease. Sci STKE, 2005. 
2005(295): p. re8. 
131. Tiruppathi, C., et al., Ca2+ signaling, TRP channels, and endothelial 
permeability. Microcirculation, 2006. 13(8): p. 693-708. 
132. Bogeski, I., et al., Differential redox regulation of ORAI ion channels: a 
mechanism to tune cellular calcium signaling. Sci Signal. 3(115): p. ra24. 
133. Hisatsune, C., et al., Regulation ofTRPC6 channel activity by tyrosine 
phosphorylation. J Biol Chem, 2004. 279(18): p. 18887-94. 
134. Trebak, M., et al., Negative regulation ofTRPC3 channels by protein kinase 
C-mediated phosphorylation of serine 712. Mol Pharmacol, 2005. 67(2): p. 
558-63. 
135. Cohen, D.M., Regulation ofTRP channels by N-linkedglycosylation. Semin 
Cell Dev Biol, 2006. 17(6): p. 630-7. 
136. Cayouette, S. and G. Boulay, Intracellular trafficking ofTRP channels. Cell 
Calcium, 2007. 42(2): p. 225-32. 
137. Abdullaev, I.F., et al., Stiml and Orail mediate CRAC currents and 
store-operated calcium entry important for endothelial cell proliferation. 
Circ Res, 2008. 103(11): p. 1289-99. “ 
138. Aubart, F.C., et al., RNA interference targeting STIMl suppresses vascular 
smooth muscle cell proliferation and neointima formation in the rat. Mol 
Ther, 2009. 17(3): p. 455-62. 
139. Shi, Y., et al., Knockdown of stromal interaction molecule 1 attenuates 
hepatocyte growth factor-induced endothelial progenitor cell proliferation. 
Exp Biol Med (Maywood). 235(3): p. 317-25. 
140. Takahashi, Y.，et al., Functional role of stromal interaction molecule 1 
(STIMl) in vascular smooth muscle cells. Biochem Biophys Res Commun, 
2007. 361(4): p. 934-40. 
141. Kumar, B.，et al., Upregulated TRPC1 channel in vascular injury in vivo and 
its role in human neointimal hyperplasia. Circ Res, 2006. 98(4): p. 557-63. 
142. Darbellay, B., et al., STIMl- and Orail-dependent store-operated calcium 
entry regulates human myoblast differentiation. J Biol Chem, 2009. 284(8): p. 
5370-80. ‘ 
143. Shin, H.Y., et al., A role ofcanonical transient receptor potential 5 channel in 
neuronal differentiation from A2B5 neural progenitor cells. PLoS One. 5(5): 
p .e l0359. 
144. Graham, S.J., et al., Stiml, an endoplasmic reticulum Ca2+ sensor, negatively 
regulates 3T3-L1 pre-adipocyte differentiation. Differentiation, 2009. 77(3): 
p. 239-47. 
113 
145. Louis, M., et al., TRPC1 regulates skeletal myoblast migration and 
differentiation. J Cell Sci, 2008. 121(Pt 23): p. 3951-9. 
146. Riddoch，F.C., et al., Changes in functional properties of the 
caffeine-sensitive Ca2+ store during differentiation ofhuman SH-SY5Y 
neuroblastoma cells. Cell Calcium, 2007. 41(3): p. 195-206. 
147. Bair, A.M., et al.，Ca2+ entry via TRPC channels is necessary for 
thromhin-induced NF-kappaB activation in endothelial cells through 
AMP-activatedprotein kinase and protein kinase Cdelta. J Biol Chem, 2009. 
284(1): p. 563-74. 
148. Pulver, R.A.，et al., Store-operated Ca2+ entry activates the CREB 
transcription factor in vascular smooth muscle. Circ Res, 2004. 94(10): p. 
1351-8. 
149. Shaywitz, A.J. and M.E. Greenberg, CREB: a stimulus-induced transcription 
factor activated by a diverse array of extracellular signals. Annu Rev 
Biochem, 1999. 68:p. 821-61. 
150. Mancini, M. and A. Toker, NFATproteins: emerging roles in cancer 
progression. Nat Rev Cancer, 2009. 9(11): p. 810-20. 
151. Buchholz, M. and V. Ellenrieder, An emerging role for “ 
Ca2+/calcineurin/NFATsignaling in cancerogenesis. Cell Cycle, 2007. 6(1): 
p. 16-9. 
152. Rao, A., C. Luo, and P.G. Hogan, Transcription factors of the NFATfamily: 
regulation and function. Annu Rev Immunol, 1997. 15: p. 707-47. 
153. Luo, C., et al., Interaction ofcalcineurin with a domain of the transcription 
factor NFAT1 that controls nuclear import. Proc Natl Acad Sci U S A, 1996. 
93(17):p. 8907-12. 
154. Ohteki, T.，et al., Negative regulation ofTcellproliferation and interleukin 2 
production by the serine threonine kinase GSK-3. J Exp Med, 2000. 192(1): p. 
99-104. 
155. Macian, F., C. Garcia-Rodriguez, and A. Rao, Gene expression elicited by 
NFAT in the presence or absence of cooperative recruitment of Fos and Jun. 
EMBO J, 2000. 19(17): p. 4783-95. 
156. Baksh, S., et al., NFATc2-mediated repression of cyclin-dependenfkinase 4 
expression. Mol Cell, 2002. 10(5): p. 1071-81. 
157. Im, S.H. and A. Rao, Activation and deactivation of gene expression by 
Ca2 +/calcineurin-NFAT-mediated signaling. Mol Cells, 2004. 18(1): p. 1-9. 
158. Horsley, V. and G.K. Pavlath, NFAT: ubiquitous regulator ofcell 
differentiation and adaptation. J Cell Biol, 2002. 156(5): p. 771-4. 
159. Lehen'kyi, V., et al., TRPV6 channel controls prostate cancer cell 
114 
proliferation via Ca(2+)/NFAT-dependentpathways. Oncogene, 2007. 26(52): 
p. 7380-5. 
160. de la Pompa, J.L., et al., Role of the NF-ATc transcription factor in 
morphogenesis of cardiac valves and septum. Nature, 1998. 392(6672): p. 
182-6. 
161. Ranger, A.M., et al., The transcription factor NF-ATc is essential for cardiac 
valve formation. Nature, 1998. 392(6672): p. 186-90. 
162. Zaichuk, T.A., et al., Nuclear factor of activated T cells balances 
angiogenesis activation and inhibition. J Exp Med, 2004. 199(11): p. 
1513-22. 
163. Horsley, V., et al., Regulation of the growth of multinucleated muscle cells by 
an NFATC2-dependentpathway. J Cell Biol, 2001. 153(2): p. 329-38. 
164. Ranger, A.M., et al., The nuclear factor of activated T cells (NFAT) 
transcription factor NFATp ft^FATc2) is a repressor of chondrogenesis, J Exp 
Med, 2000.191(1): p. 9-22. 
165. Santini，M.P., et al., Cross talk among calcineurin, Spl/Sp3, andNFAT in 
control ofp21 ffVAFl/CIPl) expression in keratinocyte differentiation. Proc 
Natl Acad Sci U S A , 2001. 98(17): p. 9575-80. “ 
166. Ho, I.C., et al., A potential role for the nuclear factor of activated Tcells 
family oftranscriptional regulatory proteins in adipogenesis. Proc Natl Acad 
S c i U S A , 1998.95(26):p. 15537-41. 
167. Heit, J.J., et al., Calcineurin/NFAT signalling regulates pancreatic beta-cell 
growth andfunction. Nature, 2006. 443(7109): p. 345-9. 
168. Pang, X. and N.L. Sun, Calcineurin-NFATsignaling is involved in 
phenylephhne-induced vascular smooth muscle cell proliferation. Acta 
Pharmacol Sin, 2009. 30(5): p. 537-44. 
169. Caetano，M.S., et al., NFATC2 transcription factor regulates cell cycle 
progression during lymphocyte activation: evidence of its involvement in the 
control of cyclin gene expression. FASEB J, 2002. 16(14): p. 1940-2. 
170. Kahl, C.R. and A.R. Means, Regulation of cell cycle progression by 
calcium/calmodulin-dependentpathways. Endocr Rev, 2003. 24(6): p. 
719-36. -
171. Viola, J.P., et al., NFATtranscription factors:from cell cycle to tumor 
development. Braz J Med Biol Res, 2005. 38(3): p. 335-44. 
172. Karpurapu, M., et aL, NFATcl targets cyclin A in the regulation of vascular 
smooth muscle cell multiplication during restenosis. J Biol Chem, 2008. 
283(39): p. 26577-90. 
173. Karpurapu, M., et al., Cyclin D1 is a bona fide target gene ofNFATcl and is 
115 
sufficient in the mediation of injury-induced vascular wall remodeling. J Biol 
Chem. 285(5): p.3510-23. 
174. Rossow, C.F., et al., NFATc3-induced reductions in voltage-gated K+ 
currents after myocardial infarction. Circ Res, 2004. 94(10): p. 1340-50. 
175. Layne, J.J., et al., NFATc3 regulates BK channel function in murine urinary 
bladder smooth muscle. Am J Physiol Cell Physiol, 2008. 295(3): p. 
C611-23. 
176. Nieves-Cintron, M., et al., Activation ofNFATc3 down-regulates the betal 
subunit of large conductance, calcium-activated K+ channels in arterial 
smooth muscle and contributes to hypertension. J Biol Chem, 2007. 282(5): p. 
3231-40. 
177. Santella, L., The role of calcium in the cell cycle:facts and hypotheses. 
Biochem Biophys Res Commun, 1998. 244(2): p. 317-24. 
178. Taylor, J.T., et al., Calcium signaling and T-type calcium channels in cancer 
cell cycling. World J Gastroenterol, 2008.14(32): p. 4984-91. 
179. Wonderlin, W.F,, K.A. Woodfork, and J.S. Strobl, Changes in membrane 
potential during the progression of MCF-7 human mammary tumor cells 
through the cell cycle. J Cell Physiol, 1995. 165(1): p. l77-85. 
180. MacFarlane, S.N. and H. Sontheimer, Changes in ion channel expression 
accompany cell cycle progression of spinal cord astrocytes. Glia, 2000. 30(1): 
p. 39-48. 
181. Wang, S., et al., Evidence for an early G1 ionic event necessary for cell cycle 
progression and survival in the MCF-7 human breast carcinoma cell line. J 
Cell Physiol, 1998. 176(3): p. 456-64. 
182. Nilius, B., G. Schwarz, and G. Droogmans, Control of intracellular calcium 
by membrane potential in human melanoma cells. Am J Physiol, 1993. 265(6 
Pt l ) :p .C1501-10. 
183. Yao, X. and H.Y. Kwan, Activity of voltage-gated K+ channels is associated 
with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer. 
LifeSci, 1999. 65(1): p. 55-62. 
184. Ng, S.Y., et al., Role of voltage-gated potassium channels in the fate 
determination ofembryonic stem cells. J Cell Physiol. 224(1): p. 165-77. 
185. Tsang, S.Y.，et al., Ectopic expression of systemic RNA interference defective 
protein in embryonic stem cells. Biochem Biophys Res Commun, 2007. 
357(2): p. 480-6. 
186. Moore, J.C., et al., Functional consequences of overexpressing the gap 
junction Gx43 in the cardiogenic potential of pluripotent human embryonic 
stem cells. Biochem Biophys Res Commun, 2008. 377(1): p. 46-51. 
116 
187. Estrada, M., et al., Capacitative calcium entry in testosterone-induced 
intracellular calcium oscillations in myotubes. J Endocrinol, 2005. 184(2): p. 
371-9. 
188. Gutierrez-Martin, Y., F.J. Martin-Romero, and F. Henao, Store-operated 
calcium entry in differentiated C2C12 skeletal muscle cells. Biochim Biophys 
Acta, 2005. 1711(1): p. 33-40. 
189. Bootman, M.D., et al.，2-aminoethoxydiphenyl borate (2-APB) is a reliable 
blocker of store-operated Ca2+ entry but an inconsistent inhibitor of 
InsP3-induced Co2+ release. FASEB J, 2002. 16(10): p. 1145-50. 
190. Ng, S.Y., et al., Role of voltage-gated potassium channels in the fate 
determination of embryonic stem cells. J Cell Physiol, 2010. 224(1): p. 
165-77. 
191. Gwack，Y., et al., Biochemical and functional characterization of Orai 
proteins. J Biol Chem, 2007. 282(22): p. 16232-43. 
192. Palmqvist, L., et al., Correlation of murine embryonic stem cell gene 
expression profiles with functional measures ofpluripotency. Stem Cells, 
2005. 23(5): p. 663-80. 
193. Boheler, K.R., et al., Differentiation of pluripotent embryonic stem cells into 
cardiomyocytes. Circ Res, 2002. 91(3): p. 189-201. 
194. Yang, X.Y., et al., Dosage-dependent transcriptional regulation by the 
calcineurin/NFATsignaling in developing myocardium transition. Dev Biol, 
2007. 303(2): p. 825-37. 
195. Coleman, K.M. and C l . Smith, Intracellular signaling pathways: 
nongenomic actions ofestrogens and ligand-independent activation of 
estrogen receptors. Front Biosci, 2001. 6: p. D1379-91. 
196. Chen, W.C., et al., Effect of 17beta-estradiol on intracellular Ca(2+) levels in 
renal tubular cells. Pharmacology, 2002. 64(2): p. 84-90. 
197. Perret, S., P. Dockery, and B.J. Harvey, 17beta-oestradiol stimulates 
capacitative Ca2+ entry in human endometrial cells. Mol Cell Endocrinol, 
2001. 176(l-2):p. 77-84. 
198. Picotto, G., G. Vazquez, and R. Boland, 17heta-oestradiol increases 
intracellular Ca2+ concentration in rat enterocytes. Potential role of 
phospholipase C-dependent store-operated Ca2+ influx. Biochem J, 1999. 
3 3 9 ( P t l ) : p . 7 1 - 7 . 
199. DeHaven, W.L, et al., Calcium inhibition and calcium potentiation of Orail, 
Orai2, and Orai3 calcium release-activated calcium channels, J Biol Chem, 
2007. 282(24):.p. 17548-56. 
200. Schindl, R., et al., Plasticity in Ca2+ selectivity of Orail/Orai3 heteromeric 
117 
channel. Proc Natl Acad Sci U S A, 2009. 106(46): p. 19623-8. 
201. Pani, B.，et al,, Activation ofTRPCl by STIM1 in ER-PMmicrodomains 
involves release of the channel from its scaffold caveolin-1. Proc Natl Acad 
Sci U S A, 2009. 106(47): p. 20087-92. 
202. Sundivakkam, P.C., et al., Caveolin-1 scaffold domain interacts with TRPC1 
and IP3R3 to regulate Ca2+ store release-induced Ca2+ entry in endothelial 
cells. Am J Physiol Cell Physiol, 2009. 296(3): p. C403-13. 
203. Kwiatek, A.M., et al., Caveolin-1 regulates store-operated Ca2+ influx by 
binding ofits scaffolding domain to transient receptor potential channel-1 in 
endothelial cells. Mol Pharmacol, 2006. 70(4): p. 1174-83. 
204. Hardin, C.D. and J. Vallejo, Dissecting the functions ofprotein-protein 
interactions: caveolin as a promiscuous partner. Focus on "Caveolin-l 
scaffold domain interacts with TRPC1 and IP3R3 to regulate Ca2+ store 
release-induced Ca2+ entry in endothelial cells". Am J Physiol Cell Physiol, 
2009. 296(3): p. C387-9. 
205. Park, J.H., M.Y. Lee, and H.J. Han, A potential role for caveolin-1 in 
estradiol-17heta-induced proliferation of mouse embryonic stem cells: 
involvement of Src, PI3K/Akt, and MAPKs pathways. Int J Biochem Cell Biol, 
2009. 41(3): p. 659-65. 
206. Ginis, I.，et al., Differences between human and mouse embryonic stem cells. 
Dev Biol, 2004. 269(2): p. 360-80. 
207. Guo, Y., B. Graham-Evans, and H.E. Broxmeyer, Murine embryonic stem 
cells secrete cytokines/growth modulators that enhance cell 
survival/anti-apoptosis and stimulate colony formation of murine 
hematopoietic progenitor cells. Stem Cells, 2006. 24(4): p. 850-6. 
208. Burdon, T., A. Smith, and P. Savatier, Signalling, cell cycle and pluripotency 
in embryonic stem cells. Trends Cell Biol, 2002. 12(9): p. 432-8. 
209. Heo, J.S. and H.J. Han, ATP stimulates mouse embryonic stem cell 
proliferation via protein kinase C, phosphatidylinositol 3-kinase/Akt, and 
mitogen-activatedprotein kinase signaling pathways. Stem Cells, 2006. 
24(12):p. 2637-48. 
210. Jirmanova, L., et al., Differential contributions of ERK and PI3-kfnase to the 
regulation ofcyclin D1 expression and to the control of the Gl/S transition in 
mouse embryonic stem cells. Oncogene, 2002. 21(36): p. 5515-28. 
211. Nilsson, L.M., et al., Novel blocker ofNFATactivation inhibits IL-6 
production in human myometrial arteries and reduces vascular smooth 
muscle cell proliferation. Am J Physiol Cell Physiol, 2007. 292(3): p. 
C1167-78. 
118 
, . 〈 -
 J
 i























 : - 。 ” „ 
. -
 ..
























'.. •• •� 
- . .. 
(. 
…. o 
CUHK L i b r a r i e s ‘ 
_ _ _ . . 
004779196 
